2015 - Lustgarten Foundation

Transcription

Dear Friends,
We are proud to share with you our 2015 annual report, which highlights our continued commitment to advancing
the scientific and medical research related to the diagnosis, treatment, cure and prevention of pancreatic cancer.
100
percent
goes
directly to
pancreatic
cancer
research
A Focused Mission and
Valued Partnership
Our mission is to advance the scientific and medical research related to
the diagnosis, treatment, cure and prevention of pancreatic cancer by:
• I ncreasing funding and support of research into the biological
mechanisms and clinical strategies related to diagnosis,
treatment and prevention
• Facilitating and enhancing the dialogue among members of the
medical and scientific communities about basic and clinical
research efforts
• Heightening public awareness of pancreatic cancer diagnosis,
treatment, and prevention and providing informational support
for patients, their families, and friends
Awards
As a result of our significant awareness-building, fundraising and research initiatives, we are proud to announce that
The Lustgarten Foundation has been honored with two noteworthy awards in 2015. These awards reinforce our commitment
to raising awareness and funding for pancreatic cancer research and provide us with renewed energy and enthusiasm to
help us reach our goal of one day finding a cure for this aggressive disease.
Charity Navigator
Long Island Business News
The Lustgarten
Foundation has been
recognized for the
seventh consecutive
year with the highest
rating as a four star
charity by Charity
Navigator, the country’s premier independent charity
evaluator – a designation that only 2 percent of the
charities rated by this prestigious organization have
received. Charity Navigator ratings demonstrate to donors
how efficiently they believe a charity will use its support,
and to what extent the charity is growing its programs
and services over time. The rating also is an invaluable
measure of the public’s opinion on how trustworthy,
ethical and fiscally responsible a nonprofit is. Please view
our profile at www.charitynavigator.org.
The Lustgarten
Foundation was
honored by Long
Island Business News
with a Nonprofit of
the Year Award, an
industry standard
for organizations
that are dedicated
to the economic and social well-being of the Long
Island, NY community. Honorees for this prestigious
Corporate Citizenship – The Business of Giving Award
were selected by a committee of business leaders for
their efforts in going above and beyond as outstanding
corporate citizens and for their commitment to the
greater good.
Cover: The organoid offers the hope of personalized cancer treatments.
Organoid image courtesy of Dannielle Engle, Ph.D., The Lustgarten Foundation
Pancreatic Cancer Research Laboratory at Cold Spring Harbor Laboratory
The pancreatic cancer landscape has dramatically changed since The Lustgarten Foundation was founded 18
years ago, and the Foundation has played a leading role in that change. By adopting a focused research strategy,
we have concentrated our efforts on working with world-renowned cancer research experts who have applied
their knowledge and expertise to charting a new course for pancreatic cancer – a path that will lead to increasing
survival rates and finding a cure.
We are making substantial progress, in spite of limited government funding for pancreatic cancer research, and we
are making it count for the patients who need our help now. In fact, 2015 marked a turning point for The Lustgarten
Foundation, as we are on the cusp of exciting scientific breakthroughs from our Lustgarten-funded researchers in
areas including immunotherapy and personalized medicine that could alter the course of pancreatic cancer and
provide a renewed sense of hope and promise for pancreatic cancer patients and their loved ones.
On the pages that follow, we highlight the noteworthy research we have funded with your support. We spotlight the
groundbreaking studies being led by our Director of Research and Distinguished Scholar, Dr. David Tuveson, at
The Lustgarten Foundation Pancreatic Cancer Research Laboratory at Cold Spring Harbor Laboratory. Dr. Tuveson
and his team are conducting multiple studies with organoids, a reproduction of a human pancreas tumor, which
will open new avenues for personalized medicine. Multiple drugs can be tested on a patient’s organoid to see which
therapy shows the best response for the patient. This is the beginning of a new way of customizing treatment,
offering hope to patients and dramatically improving patient care and prognosis.
We also report on the ongoing research conducted by our other Distinguished Scholar award recipients, Dr. Bert
Vogelstein, Johns Hopkins University School of Medicine, Dr. Ronald Evans, Salk Institute for Biological Studies,
and Dr. Douglas Fearon, Cold Spring Harbor Laboratory and Weill Cornell Medical College. These accomplished
researchers and our Research Investigators are conducting studies on early detection, immunotherapy, and
potential new treatments that will impact outcomes. Additionally, we highlight our ongoing collaboration with
Stand Up To Cancer, which now extends to four pancreatic cancer research teams that are tackling the disease
using novel approaches.
We want to take this opportunity to express our heartfelt gratitude to our many friends – our generous supporters,
volunteers, walk leaders, event sponsors, Board of Directors, and Scientific Advisory Board. As a result of your
dedication, we once again reached an all-time fundraising high of more than $20 million in 2015, and we held more
than 300 community events and over 30 Pancreatic Cancer Research Walks nationwide. And, due to the support
of Cablevision, 100 percent of every dollar donated to The Lustgarten Foundation went directly to pancreatic
cancer research.
In honor of all of the members of our patient community and their loved ones, we will continue to pursue our
mission to accelerate a path towards a cure, and we look forward to updating you on our research and fundraising
efforts throughout 2016.
Sincerely,
Charles F. Dolan
Robert F. Vizza, Ph.D.
Kerri Kaplan
Chairman
President &
Chief Executive Officer
Executive Director &
Chief Operating Officer
A Tribute To Cablevision
A Vision Fulfilled
In 1998, when a young 51-year-old Marc Lustgarten, Cablevision Vice Chairman, was
diagnosed with pancreatic cancer, Charles F. Dolan and James L. Dolan, along with
Marc, had a vision for a foundation dedicated to curing this difficult disease through
research. Our mission remains steadfast — to advance research related to the diagnosis,
treatment, cure and prevention of pancreatic cancer while raising public awareness
and providing support for patients and their families. At the time The Lustgarten
Foundation was established, pancreatic cancer was indeed an “orphan” disease, with
less than $16 million, or 0.5 percent of the total National Cancer Institute’s budget
supporting less than 15 researchers nationally. The founding fathers provided all the
initial financial support to launch The Lustgarten Foundation.
In 2008, in response to the leadership of Chairman Charles Dolan and Chief Executive
James Dolan, Cablevision committed to pay all of The Lustgarten Foundation’s
administrative expenses. This enabled the Foundation to publicly state that, “100% of
every dollar donated goes directly to pancreatic cancer research” — a most powerful
message. As a result, the impact on fundraising and research expenditures has been
dramatic, with fundraising increasing threefold from $6.7 million to nearly $20.5 million
in the period from the start of the sponsorship through 2015. Research expenditures
increased fivefold from $19 million before Cablevision’s support to a total of $118
million through 2015, making The Lustgarten Foundation the nation’s largest private
funder of pancreatic cancer research. In addition to this financial support, Cablevision
created and supported our curePC campaign, which significantly raised awareness,
provided patient information and helped increase fundraising.
As a result, The Lustgarten Foundation’s impact on research has been substantial,
supporting many major pancreatic cancer research milestones. Significant initiatives
we have undertaken include: conducting research and clinical trials that led to
the first new combination therapy in eight years; sequencing the genome;
developing a personalized medicine model; developing an early detection
blood test; harnessing the body’s own immune system to fight the
disease; and developing a deeper understanding of the molecular
biology underlying pancreatic cancer.
August 30, 1999:
Marc Lustgarten, Vice
Chairman of Cablevision
and Chairman of
Madison Square Garden,
dies of pancreatic cancer.
(Charles and Jim Dolan
establish The Lustgarten
Foundation for Pancreatic
Cancer Research, which
becomes the nation’s
largest private funder
of research for the
deadly disease.)
lity for the
me responsibi
su
as
to
on
t
en
tion so that all
Cablevision w
garten Founda rectly to funding
st
Lu
he
T
of
could go di
full overhead
to the nonprofit tion, which was established
contributions
da
2015, the foun
more than
research. As of buted over $110 million to
ri
st
arch centers
in 1998, had di ects at 60 medical and rese foundation
oj
pr
at
priv e
200 research
me the largest er research.
co
be
d
ha
d
an
reatic canc
worldwide
devoted to panc
in the country
To chronicle the amazing history and growth of Cablevision and
the role played by Charles Dolan and the Dolan family, there is a
privately published and fascinating book entitled Charles Dolan
and the Cablevision Journey. On the following page are excerpts
that describe the beginning of The Lustgarten Foundation.
2 • THE LUSTGARTEN FOUNDATION
, when
e spring of 1998
th
in
ed
rr
cu
oc
profound ways
ny’s makeup in
pa
m
co
e
th
d
.
ge that altere
ncreatic cancer
Another chan
nosed with pa
ag
di
as
w
en
rt
•
Marc Lustga
ily. He was the
ablevision fam ar, Jim pointed
C
er
rg
la
e
th
by
arts. In particul
ion
ans, as well as
ted by the Dol nation of book and street sm t the other side in a negotiat
ec
sp
re
d
an
d
ve
bi
ha
lo
w
m
e
be
co
in
a
as
w
essing
Marc
to determ
ew Yorker, poss
arkable ability
consummate N ading people, and his rem
r re
to his knack fo
d.
te
•
be a death
really wan
y accepted to
el
rg
la
as
w
it
;
er
pancreatic canc
r research for
fo
ey
on
m
tle
ere was lit
At the time, th
•
e was no
sentence.
clear that ther unch
e
m
ca
be
it
n
he
la
Cablevision. W
Jim decided to
to everyone at tment or cure, Charles and listed their industry
g
in
tt
se
up
ly
sis was deep
y effective trea
Marc. They en join a media advisory
Marc’s diagno
disease, nor an the outcome for people like
e
th
r
fo
them—to
st
te
n
urdoch among nouncements to spread
lp change
M
he
early-detectio
t
er
to
up
on
R
ti
d
da
Foun
one, an
ice an
The Lustgarten vin, Barry Diller, John Mal levision-created public serv
Le
ab
d
C
al
er
st
G
ca
d to tele
friends—
bers committe
.
Charles
board; the mem disease and the foundation
on’s president.
ti
da
un
fo
e
w
th
ne
the
cer Institute,
awareness of
would become meet with the National Can
ho
w
g
,
za
iz
V
ob
d to
Dr. B
e fourth-leadin
ch facilities an
ed for help to
, which was th
ar
rn
er
se
tu
nc
re
s
ca
so
al
ic
ou
s
ri
at
an
re
va
The Dol
ctors at
for panc
izza to visit do
finding a cure
traveled with V ore money and energy into
tm
the gravity
States.
urging it to pu
e statistics and in
in the United
as
hs
se
at
di
e
de
th
er
of
nc
e
re
ar
cause of ca
Dolans were aw e being administered anywhe
underway, the
in
e
ic
er
w
ed
m
on
e
ti
iv
da
at
e or altern
for the foun
Even as plans sis. If there was a new vaccin h
ug
no
ho
lt
ag
t it. A
of Marc’s di
sure that he go ors originally
e
ad
m
ey
th
,
the world
of his doct
nger than any
ic cancer
he survived lo
ed of pancreat
di
en
rt
ga
st
Lu
c
.
predicted, Mar
at the age of 52
in August 1999
•
None of this would have been accomplished without the support
of Cablevision. It has enabled us to build a solid, leading foundation,
and to ensure that The Lustgarten Foundation will continue to
flourish going forward. Our five-year plan projects a doubling of
our research budget so as to realize the mission envisioned by
our founders.
To Charles, James, and all at Cablevision —
we are eternally grateful and pledge to complete
your vision, our mission — an ultimate CURE
for pancreatic cancer, and we thank you
for your continued support.
y
vision Journe
able
lan and the C
o
D
s
le
r
a
h
C
Excerpts From
ity Music
age at Radio C illion,
st
on
an
ol
D
es
e venue’s $70 m
Jim and Charl
1999 to mark th t also launches The
er
ob
ct
O
in
l
Hal
even
storation. The reatic Cancer Research,
seven-month re
nc
Pa
r
fo
on
ti
Madison
unda
Lustgarten Fo levision Vice Chairman and
ab
named after C hairman Marc Lustgarten.
nC
de
ar
G
re
ua
Sq
Marc Lustgarten,
photographed by
Charles Dolan, on
a sailing trip shortly
before his death.
ANNUAL REPORT • 3
Research
In 2015, The Lustgarten Foundation initiated
its OPT (Organoids for Personalized Therapy)
trial, the first of its kind using human
pancreatic cancer organoids to impact clinical
care. This initiative is led by Dr. Tuveson and
Project Manager, Herve Tiriac, Ph.D., at The
Lustgarten Foundation Pancreatic Cancer
Research Laboratory at Cold Spring Harbor
Laboratory (CSHL). In 2014, Dr. Tuveson’s
laboratory published findings on the first
organoid model for pancreatic cancer in the
prestigious journal Cell. Now, the team aims
to apply this model to the clinic.
David Tuveson, M.D., Ph.D., Director of The Lustgarten Foundation Pancreatic
Cancer Research Laboratory at Cold Spring Harbor Laboratory,
Professor and Deputy Director of the Cancer Center at Cold Spring Harbor
Laboratory
The first in a series of organoid-based projects,
the primary goal of the OPT study is to
demonstrate the effectiveness of the organoids
as a precision medicine platform for pancreatic
The team will then conduct a retrospective
trial, in which they will compare the organoid’s
responsiveness to the therapies to the patient’s
actual clinical experience. In that way, the
accuracy of the organoid as a predictor of drug
response will be demonstrated. The next phase
of the study will be a prospective trial in which
the patient’s organoid will be tested prior to
treatment to select what could be the most
effective treatment for that patient.
With a limited treatment window following
diagnosis, there is an urgent need to correctly
identify effective therapeutic options with the
greatest likelihood to help the patient, making
the development of the organoid critical. “The
organoid represents a significant step forward
for the future of cancer treatment,” said
Dr. Tuveson. “We are confident that the OPT
trial is just the beginning of a new way of
customizing treatment at the time of diagnosis,
offering hope to patients and dramatically
improving the way that pancreatic cancer
is managed.”
Dr. Tuveson and his team have now made the
organoid technology available to the entire
pancreatic cancer research community through
an educational course offered at Cold Spring
Harbor Laboratory. Nearly 30 researchers have
taken this class to date to learn how to create
an organoid from a tumor in order to develop
a personalized approach to treating patients.
Our ultimate goal, therefore, is to make the first
adaptable personalized medicine approach
to treating pancreatic cancer, in the hopes of
increasing survival rates substantially.
Joseph Kellard
cancer patients. To accomplish this goal, CSHL
researchers will first collect 100 tumor tissues,
from both patients who have undergone surgery
and from the biopsies of metastatic patients,
from several approved clinical sites throughout
the country. The organoids will undergo a
comprehensive evaluation, including genetic
sequencing and therapeutic screening. Based
on this evaluation, researchers will be able
to characterize the patient’s organoid by its
mutations and its responsiveness to over 120
FDA-approved chemotherapeutic and targeted
therapies.
Joseph Kellard
Presently, it is difficult to determine how a
patient will respond to a particular treatment,
and therefore, the patient becomes the subject
for testing. In the laboratory, the organoid
becomes the subject for testing. The long-term
goals of the organoid research project are
to provide new, focused treatment options
for patients based on their tumor’s genetic
mutations. In this research project, the patient’s
tumor organoid is genetically sequenced,
and its genetic makeup is characterized. It
is then “treated” with many compounds and
combinations of compounds to determine
which are the most effective in killing the
cancer cells. This process — sequencing
and screening drugs — is the essence of
personalized medicine, where the precise
treatment for each individual patient is selected
based on the genetic makeup of the individual
tumor. To date, a handful of patients have
volunteered to have organoids developed for
research purposes, and the preliminary results
have been encouraging. In one case, a patient’s
organoid did not respond to the current
standard of care, and this result correlated
to the patient’s actual response to those
treatments. The organoid did respond well to
a different therapy, and as a result, the patient
was switched to that therapy.
Joseph Kellard
–D
avid Tuveson, M.D., Ph.D.
The Lustgarten Foundation’s dedicated
Pancreatic Cancer Research Laboratory
at Cold Spring Harbor Laboratory is
concentrating much of its research on the
highly innovative field of personalized cancer
treatment, marking a new era in the way
we customize treatment. At the heart of our
research program, David Tuveson, M.D., Ph.D.,
The Lustgarten Foundation’s Director of
Research, and his team are focused on creating
a personalized medicine platform using their
recently developed “organoid,” which is a
reproduction of a human tumor that offers
hope to patients for dramatically improving
their care and prognosis. An organoid can be
reproduced indefinitely in the laboratory and
then available drugs can be tested to determine
which one(s) have the best response for a
particular patient.
Joseph Kellard
“The organoid
represents a
significant step
forward for the
future of cancer
treatment. We are
confident that
the OPT trial is
just the beginning
of a new way of
customizing treatment at the time
of diagnosis...”
New Directions
In Treatment
Using Organoids
For Personalized
Medicine
Joseph Kellard
Interest in, and support for, pancreatic cancer research has grown substantially in recent years, as more scientists and clinicians
are choosing to focus on this severely underfunded disease. Today, there are more than 1,000 researchers actively working to find
a cure for pancreatic cancer, and there are nearly 750 pancreatic cancer clinical trials currently taking place across the country.
The Lustgarten Foundation has significantly contributed to the growth of pancreatic cancer research by supporting more than
200 projects at more than 60 institutions worldwide. At the end of 2015, The Lustgarten Foundation’s commitment to pancreatic
cancer research totaled more than $118 million since inception. In order to have the greatest impact on this disease, The Lustgarten
Foundation has adopted a Focused Research Strategy — with emphasis on earlier detection, personalized therapy for individual
patients and translational research to increase treatment options, which are highlighted in the research section that follows.
Researchers at The Lustgarten Foundation Pancreatic Cancer Research
Laboratory at Cold Spring Harbor Laboratory conduct innovative research
to identify new treatments for pancreatic cancer.
ANNUAL REPORT • 5
The Lustgarten Foundation Expands Collaboration
With Stand Up To Cancer (SU2C)
The Lustgarten Foundation is pleased to recognize its long-term collaboration with Stand Up To Cancer (SU2C) which now
extends to three pancreatic cancer Dream Teams and one pancreatic cancer research team engaging world-renowned scientists,
with all projects involving clinical trials, leading to patient benefits in the three-year funding cycle. To date, The Lustgarten
Foundation has committed more than $14.5 million to this collaboration for Stand Up To Cancer’s four pancreatic cancer
research teams. We believe strongly that combining our resources and best practices with SU2C strengthens our research
program and will move us more quickly towards significant progress.
SU2C brings together the best and brightest
minds to accelerate research so that new
therapies can get to patients quickly and
potentially save lives. The first pancreatic
cancer Dream Team was one of the five
inaugural 2009 SU2C Dream Teams funded
from the first SU2C telecast in 2008. Led by
Daniel D. Von Hoff, M.D., TGen, and Craig
Ted Buchanan, Med Meeting Images
–D
r. Elizabeth M. Jaffee,
Johns Hopkins
University School
of Medicine
Dream Team Program
Robert H. Vonderheide, M.D., D. Phil, University of Pennsylvania, and
Elizabeth M. Jaffee, M.D., Johns Hopkins University School of Medicine
Additionally, the Dream Team developed
a new imaging method to scan patients for
tumors, based on the presence of glutamine,
which provides the energy that the cancer cells
need to grow and survive. The Dream Team’s
research also demonstrated that early detection
of recurrent pancreatic cancer was possible by
testing blood samples for tumor DNA, called
a “liquid biopsy.” Researchers determined
that the blood tests were a more accurate way
to learn if the disease had recurred following
surgical removal of the tumor compared to
standard-of-care imaging approaches. In fact,
with the liquid biopsy, return of the disease
was identified 6.5 months sooner than through
imaging approaches.
The SU2C-Lustgarten Foundation
Pancreatic Cancer Convergence Dream
Team: Transforming Pancreatic Cancer
to a Treatable Disease, initiated in 2014
in conjunction with the Fox Family Cancer
Research Funding Trust, aims to develop new
therapies using patients’ own immune cells
to treat their cancers through the five trials
it is currently conducting. The team is also
conducting studies to develop combination
treatment approaches and biomarkers. It
brings together leading individuals in the
fields of immunotherapy, genetics, informatics,
biostatistics, regulatory/clinical trials, cancer
biology and pathology from nine institutions.
Elizabeth M. Jaffee, M.D., Johns Hopkins
University School of Medicine and Robert
H. Vonderheide, M.D., D.Phil., University of
Pennsylvania are, respectively, Leader and
Co-leader of the project.
In November 2015, the Stand Up To Cancer
(SU2C) – Cancer Research UK – Lustgarten
Foundation Dream Team: Reprogramming
of Transcriptional Circuitry to Control
Pancreatic Cancer, comprised of leading
researchers from the United States and the
United Kingdom, was announced at the AACR
Molecular Targets meeting. This third Dream
Team, led by Daniel D. Von Hoff, M.D., TGen,
and co-led by Ronald M. Evans, Ph.D., Salk
Institute for Biological Studies, and Gerard I.
Evan, Ph.D., University of Cambridge, focuses
on reprogramming pancreatic cancer cells so
that they become less aggressive and more
sensitive to drugs and anti-cancer immune
responses. Through this research, the Dream
Team’s goal is to improve the survival rate of
pancreatic cancer patients, at least doubling
the one-year survival in advanced pancreatic
cancer patients from 35 percent to more than
70 percent, and to maintain remission in
patients who have responded to treatment.
A pancreatic cancer translational research
team was formed under the direction of
Jeffrey A. Drebin, M.D., Ph.D., University of
Pennsylvania, to explore the effects of synthetic
Vitamin D on the immune cells that enter the
pancreatic cancer tumor. Dr. Drebin’s team
will conduct a clinical trial of Gemcitabine,
Abraxane and synthetic Vitamin D, followed
by treatment with an immunotherapy drug that
is currently FDA-approved for certain types of
melanoma and lung cancer.
Stand Up To Cancer
Scientific Summit
Researchers from these four pancreatic cancer
Ted Buchanan, Med Meeting Images
“We are
confident that
our research
will result in
significant
advances in
identifying new
immunotherapy
treatments.”
Thompson, M.D., Memorial Sloan Kettering
Cancer Center, the team initiated clinical
trials to test new drug combinations. Their
research resulted in the discovery of combining
Abraxane with Gemcitabine, which became
the first new drug combination therapy
approved for pancreatic cancer in eight years
(since Tarceva was FDA-approved for use with
Gemcitabine in 2005), as well as a standard
of care for patients with metastatic cancer of
the pancreas. Their research demonstrated
that Abraxane combined with Gemcitabine
increased one-year survival by 59 percent as
compared to Gemcitabine alone.
From left to right: Ronald M. Evans, Ph.D., Salk Institute for Biological Studies;
Daniel D. Von Hoff, M.D., TGen; Jeffrey A. Drebin, M.D., Ph.D., University of
Pennsylvania; and Gerard I. Evan, Ph.D., University of Cambridge
teams recently convened at the Stand Up To
Cancer Annual Scientific Summit in California,
where they had the opportunity to share ideas
and best practices and provide feedback and
suggestions for further research. This summit
is particularly valuable in allowing researchers
to share data, collaborate and achieve the best
value in their research to potentially change the
lives of thousands of patients and their families.
A Look Ahead
Our pancreatic cancer Dream Teams have
already made significant strides in our
understanding and treatment of the disease.
The cancer landscape is changing rapidly,
and The Lustgarten Foundation, in
collaboration with SU2C, believes we are
on the verge of discovering additional new,
advanced therapies that could be life-saving.
“Thanks to the
support of Stand
Up To Cancer and
The Lustgarten
Foundation,
patients and their
families should
be more hopeful
about quantity
and quality of life
than ever before.”
- Dr. Daniel D. Von Hoff,
T Gen
ANNUAL REPORT • 7
Distinguished Scholars Apply Novel Approaches
To Early Detection And Treatment
–B
ert Vogelstein, M.D.
Bert Vogelstein, M.D., Johns Hopkins
University School of Medicine, is continuing to
expand his research on a DNA-detecting blood
test for pancreatic cancer to a larger, more
diverse population. The goal of this research
is to have a reliable blood test that can be
administered at a doctor’s office during a
routine appointment.
Dr. Vogelstein is also studying the importance
of surveillance in monitoring pancreatic cysts.
In a successful study funded by The Lustgarten
Foundation, Anne Marie Lennon, M.D., Ph.D.,
and her colleagues at Johns Hopkins University
School of Medicine, led by Dr. Vogelstein,
have identified a panel of molecular markers
and clinical features that show promise for
classifying pancreatic cysts and determining
which cysts are likely to become malignant
and require surgery, and which cysts are likely
to remain benign and require monitoring
only. This important finding was published
in the November 2015 issue of the esteemed
journal Gastroenterology. This more specific
panel of markers will provide physicians with
additional information to help them decide
Focusing on more effective treatment
for patients, Dr. Bert Vogelstein and his
colleagues, Dr. Luis Diaz and Dr. Dung Le,
recently published promising results in The
New England Journal of Medicine using an
immunotherapy drug called Pembrolizumab.
Results demonstrated that cancer patients
whose tumors had a unique mutation called
“microsatellite instability” (MSI) responded
to Pembrolizumab, even when other forms of
therapy were not effective. There are potentially
2 percent or more pancreatic cancer patients
who are MSI-positive and have the opportunity
to potentially benefit from treatment with
Pembrolizumab, which is not yet FDA approved
for the treatment of MSI pancreatic cancer. As a
result of the initial results with Pembrolizumab,
The Lustgarten Foundation has launched a
public awareness campaign to recruit patients
and cover the costs to have their tumors tested
for MSI so they have the opportunity to enroll
in this promising clinical trial.
Dr. Vogelstein also published an article in the
American Association for Cancer Research’s
journal Cancer Discovery highlighting the
largest and most comprehensive genetic
analysis of hereditary pancreatic cancer
predisposition ever performed. Dr. Vogelstein
and his team sequenced the genomes of 638
patients with familial pancreatic cancers and
found that there are a number of different
genes that explain familial pancreatic cancer,
rather than just one gene, and that it is a highly
genetically diverse disease.
Ronald Evans, Ph.D., Salk Institute for
Biological Studies, is closely investigating
the relationship between pancreatic cancer
cells and the cells in the stroma, the supportive
tissue surrounding the tumor. Dr. Evans believes
that the stromal cells send growth signals to
the pancreatic cancer cells, and if these signals
are blocked, the tumor will stop growing. Dr.
Evans and his colleagues are testing how to
do this, and are aiming to block the factors
that promote the cancer. Thus far, they have
discovered that by blocking a specific growth
factor with a drug, a major cancer-causing gene
is then blocked, and could prevent pancreatic
tumor growth. Further research will be done to
confirm if this will work in patients.
In addition to this research, Dr. Evans
continues to investigate the effectiveness of a
derivative of Vitamin D in the clinical setting
through his collaboration with Brian Wolpin,
M.D., M.P.H., Dana-Farber Cancer Institute, and
Eileen O’Reilly, M.D., Memorial Sloan Kettering
Cancer Center. Drs. Wolpin and O’Reilly are
performing standard biopsies on pancreatic
cancer tumors. Dr. Evans then analyzes the
Douglas Fearon, M.D., Cold Spring Harbor
Laboratory and Weill Cornell Medical College,
is conducting research to better understand
the immune system’s role in pancreatic cancer.
Pancreatic cancer cells can prevent a person’s
immune system from attacking it by sending
“stop” signals to the immune cells, which
allows the cancer to evade cell death and
continuously grow.
Dr. Fearon’s research is investigating how
immunotherapy drugs can turn these “stop”
signals into “on” signals that can attack and
kill the cancer. He currently has a clinical
trial at Weill Cornell Medical College using
immunotherapy drugs that sensitize pancreatic
cancer cells to immune attack by boosting the
tissue biopsy samples to establish a biomarker
profile for patients whose tumors express the
Vitamin D receptor. Tumors expressing this
receptor are candidates for treatment with
paricalcitol, a synthetic Vitamin D drug that
targets and shuts down the “stromal cells”
that surround the cancer cells and prevents
chemotherapy from penetrating the tumor. By
shutting down the activity of the stromal cells,
the chemotherapy is more effective.
“Pancreatic
cancer is an
epic challenge
to both the
patient and
the family and
the job of the
scientist is
to offer new
weapons to
take control of
the disease.”
– Ronald Evans, Ph.D.
number of cancer-destroying immune cells in
the tumor.
Weill Cornell Medical College
“We now
understand this
disease on the
molecular level,
at the genetic
level, in an
unprecedented
way. All of the
genes that are
altered, and the
molecular bases
for these genetic
alterations, are
known.”
whether surgery or surveillance is the most
appropriate course of action for their patients,
based on the type of mutation they see in a
particular cyst. Certain cysts often lead to
malignancy and need to be surgically removed,
and others typically remain benign. More than
800 patients have been recruited from the
United States, Europe and the Far East for this
research, significantly surpassing the original
target of 300 patients, and this research is
scheduled for presentation at a major medical
conference in 2016.
Salk Institute for Biological Studies
Johns Hopkins Kimmel Cancer Center
The Foundation’s Distinguished Scholars grant recipients are world-class scientists at the top in their field and at the forefront of
today’s most exciting breakthroughs in pancreatic cancer research. Selected by The Lustgarten Foundation’s Scientific Advisory
Board (SAB), each grantee receives $5 million in funding over five years, enabling them to pursue high-risk, high-reward science
to accelerate a path to a cure and conduct research to improve how the disease is detected and treated.
“We’re starting
to discover that
the immune
system can,
under certain
circumstances,
help patients
who are given
certain new
drugs control
cancer growth.”
– Douglas Fearon, M.D.
ANNUAL REPORT • 9
Research Investigators Advance
The Study of Pancreatic Cancer
The Lustgarten Foundation has funded 13 prominent scientists based at top institutions across the country through our
Research Investigator program. Researchers were nominated by either the director of one of the 68 National Cancer Institute
(NCI) designated cancer centers nationwide or by members of the Foundation’s Scientific Advisory Board (SAB). Award
recipients each receive three-year grants of up to $1.5 million. We invite you to explore what each of our Research Investigators
is studying:
“There is absolutely
hope in the fight
against pancreatic
cancer, and early
detection is
one of our most
powerful tools for
conquering the
disease.”
– Alison P. Klein, Ph.D., M.H.S.,
Johns Hopkins University
School of Medicine
Dr. Cantley’s research focuses on how a
p53 mutation, the second most commonly
mutated gene in pancreatic cancer, affects cell
metabolism and cell signaling pathways that
promote pancreatic cancer.
Channing J. Der, Ph.D.
University of North Carolina, Chapel Hill, NC
Dr. Der’s study focuses on the proteins that
KRas signals to. His research has revealed
important findings about what makes a cancer
cell sensitive or resistant when targeting the
KRas pathway. This will help immensely as we
aim to find a drug to target KRas, the mutation
found in almost all pancreatic cancer patients.
Stephen W. Fesik, Ph.D.
Vanderbilt University Medical Center,
Nashville, TN
Dr. Fesik’s study aims to target other proteins
that interact with the mutated KRas protein
by using specially designed small molecule
inhibitors that he created in hopes of
indirectly killing KRas-expressing cancer cells.
Charles S. Fuchs, M.D., M.P.H.
and Mandar Muzumdar, M.D.
Dana-Farber Cancer Institute
and Massachusetts Institute of Technology,
Boston, MA
This research, being conducted simultaneously
in humans and in mouse models, aims at better
understanding how obesity and diabetes
correlate to pancreatic cancer.
Dr. Leach’s project uses a systematic approach
to testing a very large number of different drug
combinations in hopes of finding some that
work best for certain groups of patients, based
on specific biomarkers that would make patients
appropriate candidates for particular drugs.
Tony Hunter, Ph.D.
Salk Institute for Biological Studies,
La Jolla, CA
Scott W. Lowe, Ph.D.
Memorial Sloan Kettering Cancer Center,
New York, NY
Dr. Hunter’s study aims to more closely
examine the relationship between cancer
and stromal cells and identify pro-cancerous
growth factors in hopes of targeting these
factors to starve and kill the pancreatic cancer
cells. Dr. Hunter’s research to date has
demonstrated that when a specific cancerpromoting signal is blocked, mice with
pancreatic cancer are living longer.
Dr. Lowe’s research uses powerful genetic
screening tools to identify genes that
pancreatic cancer cells depend upon in
hopes of more selectively and effectively
killing cancer cells. In conjunction with Steven
Leach, M.D., Dr. Lowe is using a new model
for pancreatic cancer — the “speedy mice” —
that develops pancreatic cancer more quickly
than the conventional models, allowing for a
significant number of drug combinations to
be tested in a short time.
Tyler Jacks, Ph.D.
Massachusetts Institute of Technology,
Cambridge, MA
Dana-Farber Cancer Institute
Dr. Jacks is using new-age genetic screening
technology to discover more easily
“druggable” gene products that mutant
KRas-expressing cells are dependent upon
to target, instead of KRas itself. Dr. Jacks will
investigate how cancer cells will react if we
effectively inhibit mutant KRas.
Steven D. Leach, M.D.
Memorial Sloan Kettering Cancer Center,
New York, NY
Alison P. Klein, Ph.D., M.H.S.
Johns Hopkins University School
of Medicine, Baltimore, MD
Dr. Klein is developing and validating models
that clinicians can use to identify individuals
who are at the highest risk of pancreatic
cancer and therefore should be targeted for
early detection screening. These risk factors
include exposure to cigarette smoke, diabetes,
pancreatitis (inflammation of the pancreas)
and a family history of pancreatic cancer.
Frank McCormick, Ph.D., F.R.S.
RAS Initiative National Advisor, Frederick
National Laboratory for Cancer Research,
National Cancer Institute, Frederick, MD
University of California, San Francisco,
San Francisco, CA
Dr. McCormick’s study aims to target the stem
cell markers expressed on KRas expressingpancreatic cancer cells in hopes of sensitizing
them to chemotherapy and killing them. He
has discovered a way to reverse the cancerpromoting signals of KRas.
Hidde L. Ploegh, Ph.D.
Massachusetts Institute of Technology,
Cambridge, MA
Dr. Ploegh is developing a novel, non-invasive
approach to imaging very small tumors,
even smaller than what is detectable with the
current standard of imaging.
Stanford University School of Medicine
Lewis C. Cantley, Ph.D.
Weill Cornell Medical College, New York, NY
Julien Sage, Ph.D.
Stanford University School of Medicine,
Stanford, CA
Dr. Sage’s research targets a different class of
proteins, known as KMTs, which play a role in
pancreatic cancer progression. He has found a
new cancer-causing protein that is a potential
drug target, and he is now testing the effects
of some therapies on this new target. Dr. Sage
and his team are also focusing their research
on combination therapies. If the therapies
work together in a synergistic fashion, this
could enhance the treatment response and
reduce the chance of therapeutic resistance.
Diane M. Simeone, M.D.
University of Michigan Medical Center,
Ann Arbor, MI
Dr. Simeone’s study aims to sort and collect
circulating tumor cells in a patient’s blood
and then grow them in the laboratory for
therapeutic testing and genetic sequencing.
“We’ve learned a
great deal about
the molecular
wiring of pancreas
cancers, and we’re
in a position now
to take advantage
of that knowledge
with new treatment
strategies.”
– Tyler Jacks, Ph.D.,
Massachusetts Institute
of Technology
ANNUAL REPORT • 11
Cutting-Edge Research Influences Patient Outcomes
With an overall survival rate of just 8 percent over five years, we don’t hear often enough about the courageous men and women
who are beating these odds and giving a new face to the fight against pancreatic cancer. At this pivotal time in pancreatic
cancer research, when we are on the cusp of potential scientific breakthroughs, we highlight below the inspiring stories of four
pancreatic cancer patients and survivors who have benefited from Lustgarten-funded research that is having a profound impact
on the detection and treatment of this disease.
The Life-Changing Power of
Immunotherapy Treatment
In 2014, 52-year-old engineer David Blevins
was diagnosed with pancreatic cancer that had
metastasized to his liver. After a year of grueling
chemotherapy treatment so debilitating that
he was frequently unable to work, he threw his
energy into finding a clinical trial. His research
led him to Dr. Dung Le of Johns Hopkins
University, and while he didn’t qualify for the
initial trial he was hoping to participate in, Dr. Le
convinced him to have his tumor tested for a
rare MSI mutation (see page 8). On the same
day that he was told by one of the many leading
medical centers that he visited that there was
nothing left to offer him besides chemotherapy,
he received the life-changing call from Dr. Le that
his tumor tested positive for the mutation. He was
the first patient enrolled in a clinical trial for an
immunotherapy drug targeting MSI, sponsored
by The Lustgarten Foundation. Now, after more
than 30 treatments over 14 months, David is
doing phenomenally well. He is working again,
experiencing minimal, manageable side effects
and is fully engaged in his active family life with
his wife and four children. At his most recent
The Life-Saving Impact
of Early Detection
In 1994, retired surgeon Thomas Collins joined
the National Familial Pancreas Tumor Registry
at Johns Hopkins University, spearheaded
by Dr. Ralph Hruban, a Lustgarten-funded
researcher who focuses on early detection and
familial pancreatic cancer. Tom was deeply
concerned after several of his relatives, including
his mother, passed away from pancreatic cancer.
As part of the Lustgarten-funded CAPS (Cancer
of the Pancreas Screening) research study led by
Dr. Marcia Canto, a colleague of Dr. Hruban’s at
Johns Hopkins University, Tom started making
the trip from his home in Maine to Baltimore
for an annual endoscopic ultrasound screening.
Dr. Canto told him that few people continued
coming for a screening for so many years; doing
so most likely saved his life. During his eleventh
screening in 2013, the ultrasound revealed a
lesion the size of a pencil eraser – the smallest
pancreatic cancer tumor to date discovered at
Johns Hopkins. Tom underwent surgery and
then 18 rounds of chemotherapy infusions.
scan, there was no evidence of any more liver
metastases, and his pancreas tumor had shrunk
by more than 68 percent. And, because an MSI
trial site recently opened at Ohio State University,
he no longer needs to travel
from his home in Indiana twice
every month
to Johns
Hopkins in
Baltimore
for his
infusions.
Success with the First
Pancreatic Cancer Vaccine
David Blevins and
his wife Carol
Photo courtesy
of David Blevins
Kathleen Dowell was only 50 years old when she was
diagnosed with pancreatic cancer in 1997, after doctors
initially mistook her symptoms for gallstones. At first she
was in complete shock and disbelief, as very little was even
known about pancreatic cancer, and then she feared she
would never live to see her newborn grandchild grow up.
After undergoing surgery and chemotherapy, Kathleen
was approached by Dr. Elizabeth Jaffee’s team at Johns
Hopkins University to participate in a small study
testing the first adjuvant pancreatic cancer vaccine
(GVAX). She recalls her surgeon Dr. Cameron saying
to her, “Mrs. Dowell, you could be the one to survive,”
and those words were the encouragement she needed
to try the vaccine. After just two GVAX doses, she
became ineligible to continue due to complications
from her prior chemotherapy treatment. However, she
had the highest immune response of anyone in the
study and now, 18 years later, she is cancer-free and
has watched all four of her grandchildren grow up. The
Lustgarten Foundation has funded Dr. Jaffee’s ongoing
research on the GVAX vaccine.
Kathleen Dowell (4th from left) surrounded by
Dr. Dan Laheru (2nd from left), Dr. Elizabeth Jaffee
(3rd from left), and the rest of her medical team
Photo courtesy of Johns Hopkins University
BRCA Mutation and Pancreatic
Cancer Treatment
Now, more than two years after surgery, Tom has
been given a second chance on life and runs a
cancer support group, sharing his story of hope
with other pancreatic
cancer patients and
their loved ones.
Dr. Ralph Hruban
with Tom Collins
Photo courtesy
of Dr. Hruban
In 2015, Jim Foley, a 71-year-old retired engineer and
15-year prostate cancer survivor from Westchester
County, New York, was undergoing genetic testing
to determine if he had the BRCA mutation, which
two of his daughters and other family members
have, when a routine CT scan for his long-term
prostate cancer showed that he had a pulmonary
embolism and metastatic pancreatic cancer. His
entire world was turned upside down, as he learned
that the embolism was caused by Stage IV pancreatic
cancer that had metastasized to the liver. He was
immediately referred to Dr. Eileen O’Reilly at
Memorial Sloan Kettering Cancer Center, where
he was also being treated for his prostate cancer.
He learned that he tested positive for the BRCA
mutation, which Dr. O’ Reilly said was actually
beneficial because it gave her a roadmap for
how to treat his tumor. She also said that BRCA
patients often respond very well to standard of care
chemotherapy. Now, a year since diagnosis, Jim
shows no signs of slowing down. The tumor in his
pancreas is not detectable and the lesions in his
liver are dramatically reduced; in fact, his CA 19-9
and CEA tumor marker levels are now within the
normal range. Jim experiences few side effects on
the standard of care treatment regimen. Jim is busy
spending his time with his wife, three daughters,
and seven grandchildren. Jim also led Team Foley’s
Fighters at the Foundation’s recent Westchester
Pancreatic Cancer Research Walk, raising $3,300
for critical research.
Jim Foley walks in
Dr. O’Reilly's honor
at the Westchester
Pancreatic Cancer
Research Walk
Photo courtesy
of Kerri Kaplan
The Lustgarten Foundation is funding two
significant initiatives focused on the BRCA
mutation. Several patients in a trial funded
by The Lustgarten Foundation and led by
Dr. Eileen O’Reilly at Memorial Sloan Kettering
Cancer Center are having impressive results
taking a PARP inhibitor in combination with
cisplatin and gemcitabine. According to
Dr. O’Reilly, the trial is likely to define a
standard treatment approach for people
with BRCA mutations. The Lustgarten
Foundation is also funding the first
comprehensive registry for people with
a BRCA mutation, as well as those with
a family history of BRCA mutations.
This initiative is spearheaded by
Dr. David Kelsen at Memorial Sloan
Kettering Cancer Center.
The Lustgarten Foundation and Cablevision Systems Corporation
partnered in the curePC campaign, an award-winning public service
campaign that raises awareness about pancreatic cancer and the
Foundation’s efforts in the battle against this disease.
1 Team. 1 Mission.
The curePC campaign’s series of online and print public
service announcements (PSAs), “1 Team. 1 Mission.,”
highlights how everyone’s contributions matter in the
fight to beat pancreatic cancer. The series features the
many team members – scientists, physicians, volunteers,
caregivers and fundraisers – whose efforts help us make a
difference.
Pictured left: Dr. Eileen O’Reilly, Memorial Sloan Kettering
Cancer Center, and Joseph, a walk participant.
Pancreatic Cancer
Awareness Month
In recognition of Pancreatic Cancer Awareness Month this
past November, the curePC campaign launched a multifaceted
online and social media initiative featuring easy ways to raise
awareness and join #TeamcurePC. And on November 13, many
Foundation supporters, including celebrities and members
of the media, joined together for a special social media effort
to mark World Pancreatic Cancer Day, reaching more than 12
million followers.
Pictured right: Dr. Dannielle Engle, Cold Spring Harbor
Laboratory, and Garrett, a future researcher, fundraiser
and student.
#WalkToCurePC
The curePC campaign continued to raise awareness of the
Foundation’s largest walks, including the Foundation’s flagship
walk on Long Island. Held in October, the Long Island Walk
welcomed 8,000 participants and raised $1.3 million.
For more on the Foundation’s national walk series, see page 18.
Anthony Carrino and John Colaneri, the popular stars of
HGTV’s “Kitchen Cousins,” “Cousins on Call” and “America’s
Most Desperate Kitchens,” showed their support of the
Foundation by appearing in television and print public
service announcements for the curePC campaign. The PSAs
emphasize the early detection research that the Foundation
is funding and the great hope that this potentially life-saving
research may offer.
Brian Stanton
New PSAs with HGTV’s
“Cousins”
100% of every dollar donated to The Lustgarten Foundation
goes directly to pancreatic cancer research.
Events
Committee
members (l-r)
Hope Wolfe,
Stacy Remnitz,
Shari Dusansky
and their
daughters.
Partygoers give
a thumbs up
after testing
the track!
On December 16th, Cablevision Systems Corporation,
The Madison Square Garden Company, and AMC
Networks hosted the 15th annual Holiday Rock & Roll
Bash to benefit The Lustgarten Foundation. Held for the
first time at the exclusive TAO Downtown in New York
City, the Bash attracted over 1,000 people and raised
more than $2 million for the second consecutive year,
with 100 percent of every dollar raised going directly to
support pancreatic cancer research. Since its inception
in 2001, the Holiday Rock & Roll Bash has raised $21
million for pancreatic cancer research.
On January 30th, more than 300 guests attended our
3rd annual New York City winter fundraiser, Party with a
Purpose, held at the famous Marquee in the West Village.
Guests enjoyed creative cuisine, danced to the sounds of
DJ Matt Winters, participated in an auction with soughtafter prizes, and were entertained by a strolling magician
and a dancing robot. Special thanks to our presenting
sponsor Celgene and the dedicated event committee.
Party with a Purpose garnered nearly $185,000, bringing
the total raised from this event to more than $407,000.
On February 6, the inaugural Race 4 A Cure took
place at Grand Prix New York, an entertainment
complex in Westchester County. Led by more than
a dozen committee families from the surrounding
community who have been impacted by pancreatic
cancer, the event’s family-driven format brought
together kids, teens and adults in the quest for a cure.
With entertainment and music provided by Total
Entertainment, indoor go kart racing, bowling, a
bounce house and arcade, it was a fun-filled night for
all. The fundraiser, emceed by Lisa LaRocca of News
12 Westchester, featured passed hors d’oeuvres from
highly acclaimed local restaurants and a dinner and
dessert buffet. Attendees also enjoyed a silent auction
offering prizes including vacation packages, sports
memorabilia, gift cards from top-rated restaurants,
and show tickets and entertainment. The fundraiser
attracted 400 people and raised more than $140,000
for The Lustgarten Foundation.
We are proud to have worked with many dedicated supporters, patients and friends to increase awareness of
pancreatic cancer and raise significant research funding through community events held across the country.
We have highlighted some of our long-standing events below, as well as the people who have inspired them.
Kevin Wood
During the program, Andrew and Jessica Lustgarten
paid tribute to their late father Marc Lustgarten, who
passed away from pancreatic cancer in 1999. They were
joined by James Dolan, chief executive of Cablevision
and executive chairman of The Madison Square Garden
Company, who expressed his deep appreciation to the
corporate sponsors whose generous donations to the
Bash support the Foundation’s mission to find a cure.
James Dolan and Cablevision Chairman Charles Dolan
helped establish The Lustgarten Foundation in 1998
in honor of Mr. Lustgarten, who served as the former
vice chairman of Cablevision and chairman of Madison
Square Garden before he died from pancreatic cancer.
The dancing
robot entertains
an enthusiastic
attendee.
Ben Asen
Party with a Purpose
Cathy Burnham
Avi Gerver
Holiday Rock & Roll Bash
Race 4 A Cure
Ben Asen
DJ Questlove,
popular drummer
of The Roots
(house band
for The Tonight
Show Starring
Jimmy Fallon),
performs at TAO
Downtown to a
crowd of more
than 1,000
Bash guests.
Ben Asen
The Rockettes
give an exclusive
Radio City
Christmas
Spectacular
performance at
the 15th annual
Holiday Rock
& Roll Bash
to benefit The
Lustgarten
Foundation.
Avi Gerver
Our community outreach initiatives continued to expand in 2015. With nearly 300 fundraisers and community events, we are
propelled forward by the momentum, spirit and dedication of our valued volunteers, corporate sponsors, friends and other
supporters who make these events possible and who so significantly contribute to our ability to fund cutting-edge research.
Members of the Ivanoski family gather to honor
Eddie at the 2015 golf outing.
Mayor Margot Garant, past commodore Charles
Chiaramonte, Ralph Macchio, Maurice DuBois, and
commodore John Ciarelli attend the regatta.
Eddie Ivanoski Memorial Golf
Tournament
Village Cup Regatta
The golf tournament honors the legacy of Edward
“Eddie” Ivanoski, who served with the Marine Corps
and as a Boston police officer and detective for 40
years. Eddie passed away from pancreatic cancer —
one of five members of his family to die from the
ravaging disease that also took the lives of his brother
Leonard Ivanoski, two sisters Jean Morris and Irene
White and nephew John Morris. The annual golf
event, started in 2005, celebrates Eddie’s love for the
sport and provides an opportunity for the Ivanoski
family and their entire community to join together
to raise money for a disease that has taken so much
from them. To date, the event has raised nearly
$229,000 for The Lustgarten Foundation’s research
initiatives.
The Village Cup Regatta was founded in 2010 by
the Port Jefferson Yacht Club (formerly the Setauket
Yacht Club) located on Long Island, New York as
an annual event to raise funds for research related
to the treatment and cure of pancreatic cancer. On
September 12th, two teams — one comprised of Port
Jefferson residents, and one made up of hospital staff —
raced 30 boats amidst the cheers of hundreds of
spectators. Actor/director Ralph Macchio and Maurice
DuBois, who anchors the evening news for New York’s
CBS affiliate and who grew up in Port Jefferson,
served as the Village Cup Ambassadors. The Village
Cup Regatta has raised $304,000 since inception,
with funds shared equally between The Lustgarten
Foundation and John T. Mather Memorial Hospital’s
Palliative Care Program, located in Port Jefferson.
2015 Financial Highlights
Walks/Runs
The Lustgarten Foundation’s nationwide walk program brings together patients, their families and loved ones, community
leaders, corporations and business owners in the fight against pancreatic cancer. The events support The Lustgarten Foundation’s
mission of funding research and increase awareness of pancreatic cancer in communities across the country. They also provide
the opportunity for all those affected by the disease to gather together in the spirit of hope and to celebrate the promise of
research and the potential for a cure.
Cash, Investments and Receivables
$58,047,588
$55,941,964
Outstanding Funds Committed to Research
$40,015,342
$49,112,152
Unrestricted Undesignated Net Assets
$17,315,601
$6,675,360
Research Expenditures
$19,386,821
$14,226,765
Annual Fundraising Revenue
$20,484,436
$19,481,221
Liz Morales
2000-2015 ANNUAL FUNDRAISING REVENUE
David Laake
Ben Asen
$15,000,000
$10,000,000
$5,000,000
Ben Asen
Kevin Kennedy
$0
Thank you to all the walk leaders and volunteers and congratulations to all those who organized and participated
in the 2015 events, which surpassed past years in terms of how much funding the walks have raised for research!
Albany, NY
Bridgewater, NJ
Boston, MA
Brooklyn, NY
Cedar Rapids, IA
Chicago, IL
Cromwell, CT
Denver, CO
Dutchess County, NY
20152014
$20,000,000
Photo Courtesy of Tara Shanes-Hernandez
–R
ichard D. Goldstein, Long Island
walk team leader
$25,000,000
We could not be more grateful to our
sponsors, teams, walkers and volunteers
who joined us and helped the walk
program raise considerably more for
research than it did in past years.
“With every mile I walk,
and every dollar I raise for
The Lustgarten Foundation,
I am honoring my brother’s
memory.”
DECEMBER 31
The audited financial statements of The Lustgarten Foundation are available on our website or upon request.
Ben Asen
In 2015, more than 19,000 people
participated in our 31 walks. With
events in 14 states, representing every
corner of the country, the Pancreatic
Cancer Research Walk series raised
more than $3.9 million — a 4 percent
increase over 2014 — in our quest to
find a cure for pancreatic cancer. This
brings our walk program total to nearly
$31 million, since our first walk was
held in 2001 on Long Island, NY.
Fairfield County, CT
Fremont, CA
Fort Myers, FL
Green Valley, AZ
Howard County, MD
Lehigh Valley, PA
Long Island, NY
Middlesex, NJ
Milford, CT
Monmouth County, NJ
Naperville, IL
New York City, NY
Paramus, NJ
Pemberville, OH
Pennsauken, NJ
San Francisco, CA
St. Louis, MO
Syracuse, NY
Valley of the Sun, AZ
Westborough, MA
Westchester, NY
Westlake Village, CA
’00
’01
’02
’03
’04
’05
’06
’07
’08
’09
’10
’11
’12
’13
’14
’15
2000-2015 CUMULATIVE RESEARCH GRANTS
$120,000,000
$100,000,000
$80,000,000
$60,000,000
$40,000,000
$20,000,000
$0
’00
’01
’02
’03
’04
’05
’06
’07
’08
’09
’10
’11
’12
’13
’14
’15
e
lativ
Leadership
Donors
BOARD OF DIRECTORS
CORPORATE ADVISORY BOARD
SCIENTIFIC ADVISORY BOARD
Charles F. Dolan
Chairman
Cablevision Systems Corporation
The Honorable Jimmy Carter
Honorary Chairman
Ronald M. Evans, Ph.D.
Our important mission could not be accomplished without the assistance of the many generous
individuals, foundations, corporations, volunteers and organizations that support us. We wish there
was enough space to thank each individual who has ever made a gift, however please know that
each gift is deeply appreciated.
Frank A. Bennack Jr.
Former Chief Executive Officer
Hearst Corporation
Douglas T. Fearon, M.D.
Cold Spring Harbor Laboratory &
Weill Cornell Medical College
FOUNDERS
Barry Diller
Chairman and Senior Executive
IAC/InterActiveCorp and Expedia, Inc.
Tyler Jacks, Ph.D.
Massachusetts Institute of Technology
William Bell
Retired Vice Chairman
James L. Dolan
Chief Executive Officer
Executive Chairman
The Madison Square Garden Company
Jennie Fortunoff
Principal
Esterow Events & Consulting, Inc.
Anne Glauber
Managing Partner and Founder,
Corporate Social Responsibility and
Social Impact Practice
Finn Partners
Kerri Kaplan
Executive Director and
Chief Operating Officer
The Lustgarten Foundation
Andrew Lustgarten
Executive Vice President, Corporate
Development and Strategy
Jessica Lustgarten
Manager, Strategy and Analysis
DigitasLBi
Marcia Lustgarten
Director, Optimum Community
Sheila Mahony
Retired Executive Vice President,
Communication, Government,
and Public Affairs
Charles R. Schueler
Executive Vice President, Media
and Community Relations
Adam Silver
Commissioner
National Basketball Association
Robert F. Vizza, Ph.D.
President and Chief Executive Officer
The Lustgarten Foundation
John S. Hendricks
Founder and Former Chairman
Discovery Communications
Mel Karmazin
Retired Chief Executive Officer
Sirius XM Radio, Inc.
Co-Founder
Infinity Broadcasting
David Paul Kelsen, M.D.
Memorial Sloan Kettering Cancer
Center
Robert J. Mayer, M.D.
Dana-Farber Cancer Institute &
Harvard Medical School
Bruce Stillman, Ph.D.
Cold Spring Harbor Laboratory
Gerald M. Levin
Retired Chief Executive Officer
Time Warner, Inc.
David Tuveson, M.D., Ph.D.
The Lustgarten Foundation Pancreatic
Cancer Research Laboratory,
Cold Spring Harbor Laboratory
John C. Malone
Chairman
Liberty Media Corporation
Bert Vogelstein, M.D.
The Johns Hopkins University School
of Medicine
Rupert Murdoch
Executive Chairman
News Corp
Executive Co-Chairman
21st Century Fox
Sumner M. Redstone
Chairman Emeritus
Viacom and CBS Corporation
Chairman
National Amusements
Tom Rogers
Non-Executive Chairman
TiVo, Inc.
Sir Howard Stringer
Non-Executive Director
British Broadcasting Corporation
Retired Chairman of the Board
Sony Corporation
Bob Wright
Retired Vice Chairman of the Board
General Electric
Bill and Ellen Bell
Charles B. Wang Foundation
Mr. and Mrs. Frederick DeMatteis
Mr. and Mrs. Charles F. Dolan
Mr. and Mrs. James L. Dolan
Mr. and Mrs. Amos B. Hostetter Jr.
Mr. and Mrs. John T. Lockton III
McMullen Family Foundation
Mr. and Mrs. F.F. Randolph Jr.
The Lustgarten Family
Mr. and Mrs. Leonard Tow
CHAIRMAN’S CIRCLE $500,000 + Cumulative Since Inception
AMC Networks
Estate of Dorothy C. Guida
Estate of Lucille L. Tirkfield
Estate of Mary Brenneisen
Estate of Maxine Stein-Kohler
Estate of Patricia C. Galgan
Estate of Roberta Coppola
JCPenney
Karen Zissu-Magidson Memorial Fund
KPMG, LLP
Ruth and David Levine
Levon Graphics Corporation
Mr. and Mrs. John T. Lockton III
Mark Broxmeyer Memorial Fund
News Corporation
Rolfe Pancreatic Cancer Foundation
Shostak Charitable Fund
The Bern Schwartz Family Foundation
The Walter B. Wriston Fund
Theodore W. Batterman Family
Foundation, Inc.
Mr. Charles Wang
PRESIDENT’S CIRCLE $100,000 - $499,999 Cumulative Since Inception
21st Century Fox
Amdocs Broadband Cable &
Satellite Division
Arris
Ms. Adrienne Atkinson
Mrs. Cornelia T. Bailey
Bank of America
Barbara Montani Santaniello Research
Fund, Inc.
Bear Stearns Companies, Inc.
Bill and Ellen Bell
Black Twig Communications, LLC
Boston Scientific Corporation
Brindell Roberts Gottlieb Trust
Brisbin Brook Beynon, Architects
Celgene Corporation
Cisco Systems, Inc.
Clare Rose Foundation, Inc.
Mrs. Dorothy Daly
Debevoise & Plimpton LLP
Deloitte & Touche
DevelopOnBox LLC
Discovery Communications, LLC
Disney and ESPN Media Networks
Eli Lilly and Company
ESPN, Inc.
Estate of Florence E. Wilson
Estate of John A. Ryvik
Estate of Judith Bandel
Estate of Laurie Lima
Estate of Suzanne Rapier
Fashion Accessories Benefit Ball
Forchelli, Curto, Deegan, Schwartz,
Mineo & Terrana
Frank J. Antun Foundation
Mr. and Mrs. Ronald Frankel
Frenz For A Cause, Inc.
Frontier Touring
Gardner Nelson & Partners, Inc.
Genentech, Inc.
George L. Ohrstrom Jr. Foundation
Gibson, Dunn & Crutcher LLP
Greater Hartford Community
Foundation, Inc.
Mr. Leo A. Guthart
HJ Kalikow & Co., LLC
HBO
Hope Foundation
Mr. and Mrs. Amos B. Hostetter Jr.
Howard Shapiro Memorial Fund
Hughes Hubbard & Reed LLP
IBM Employee Charitable Contribution
Campaign
ImClone Systems Incorporated
James S. Swinehart Memorial Fund
John Alexander Wilkins III Memorial
Fund
JPMorgan Chase
Jeffrey Rosenzweig Foundation For
Pancreatic Cancer Research
Jenner & Block LLP
Jones Day
Kansys, Inc.
Kauff McGuire & Margolis LLP
Kelley Drye & Warren LLP
Lazarus Marketing, Inc.
Loeb & Loeb LLP
Mr. and Mrs. Bruce Martin
Merrill Lynch
Mintz, Levin, Cohn, Ferris, Glovsky and
Popeo, P.C.
Miramax Films
Morgan Stanley
Morgan, Lewis & Brockius LLP
MTV Networks, Inc.
NBA Cares
NBCUniversal
Neil M. Klatskin Foundation, Inc.
Newsday
Nokia Siemens Networks
OSI Foundation
Paul, Weiss, Rifkind, Wharton &
Garrison LLP
Mr. Robert F. Penardi
Pharmacia & Upjohn Co.
Port Jefferson Yacht Club (formerly
Setauket Yacht Club)
Mrs. Richardson Pratt Jr.
Mrs. F.F. Randolph Jr.
Ropes & Gray LLP
Mr. and Mrs. David E. Salmanson
Samsung
Mrs. Kathryn Schulberg
Scientific-Atlanta, Inc.
Shearman & Sterling LLP
Showtime Networks, Inc.
Mr. Adam Silver
Tom's Cure Pancreatic Cancer Foundation
Mr. Leonard Tow
Turner Broadcasting Systems, Inc.
UBS Financial Services, Inc.
Mr. and Mrs. Mark Udell of London
Jewelers
Verizon Communications
Viacom
Virginia Grande Schwenk
Wasily Family Foundation
West New York Restoration of CT, Inc.
William Morris Endeavor Entertainment
Willkie Farr & Gallagher LLP
WLNY TV 10/55
Suzanne and Bob Wright
This listing reflects the total amount of donors’ commitments from January 1, 2015 to December 31,
2015, including gifts, pledges, and payments on prior-year pledges of $1,000 or more.
Celgene Corporation
Estate of Dorothy C. Guida
Estate of Laurie Lima
Estate of Mary Brenneisen
Estate of Patricia C. Galgan
George L. Ohrstrom Jr. Foundation
Mark Broxmeyer Memorial Fund
Rolfe Pancreatic Cancer Foundation
The Antoinette E. (“Mimi”) & Herman
Boehm Foundation
The Bern Schwartz Family Foundation
The Walter B. Wriston Fund
Theodore W. Batterman Family
Foundation, Inc.
Virginia Grande Schwenk
Suzanne and Bob Wright
PLATINUM CIRCLE
$50,000 - $99,999
21st Century Fox
Arris
Bank of America
Boston Scientific Corporation
ESPN, Inc.
Estate of Richard Spinolas
Estate of Rona Brozen
Gibson, Dunn & Crutcher, LLP
Greater Hartford Community
Foundation, Inc.
Hope Foundation
Kauff McGuire & Margolis LLP
KPMG, LLP
Ropes & Gray LLP
Mr. Adam Silver
Sullivan & Cromwell LLP
The Charles B. Wang International
Foundation
The Henry and Marilyn Taub Foundation
The Ralph C. Marcove Cancer Research
Fund, Inc.
Wasily Family Foundation
Verizon Communications
GOLD CIRCLE
$25,000 - $49,999
AMC Networks
Data-Mail, Inc.
Debevoise & Plimpton LLP
Deloitte & Touche
Discovery Communications
Estate of John Alexander Wilkins III
Estate of Thomas J. Furlong Jr.
Estate of Thomas Zimmerman
Mr. Robert P. Flicker
Foundation For A Better World, Inc.
Mr. and Mrs. Kenneth Fuirst
Hughes Hubbard & Reed LLP
Infinera Corporation
IWCO Direct
James S. Swinehart Memorial Fund
JPMorgan Chase
Jenner & Block LLP
Karen Zissu-Magidson Memorial Fund
Ruth and David Levine
Linda J. Verville Cancer Research
Foundation
Dr. Edward Loeb and Family
Mintz, Levin, Cohn, Ferris, Glovsky and
Popeo, P.C.
Morgan, Lewis & Brockius LLP
NBA Cares
NBCUniversal
Neptune Township - NJ
Patterson Belknap Webb & Tyler LLP
Paul, Weiss, Rifkind, Wharton &
Garrison LLP
PJT Partners
Port Jefferson Yacht Club (formerly
Setauket Yacht Club)
Pound The Pavement
Mr. and Mrs. Peter C. Richardson
Samsung
Mr. and Mrs. Gregory Seck
Showtime Networks, Inc.
The Benevity Community Impact Fund
The Clarissa & Edgar Bronfman Jr.
Foundation
The Richard E. Capri Foundation
Time Warner, Inc.
Mr. and Mrs. Mark Udell of London
Jewelers
Zodiac Interactive
SILVER CIRCLE
$10,000 - $24,999
A & E Television Networks
Aaliyah Memorial Fund, Inc.
Abbe Berman Foundation Trust
Access It Group
AI Media Group, LLC
Alcatel-Lucent
Amdocs Broadband Cable & Satellite
Division
Andree Wildenstein Dormeuil & Roger
Dormeuil Foundation
Ms. Adrienne Atkinson
B&F Johnstone Supply
Baldor Specialty Foods
Barclays Capital
Thomas Cifardi
DIAMOND CIRCLE
$100,000 +
Mrs. Linda K. Berger
Bethpage Federal Credit Union
Bloomingdale, NJ Fire Department
BNP Paribus
Mrs. Barbara A. Bradley
Breakfast Club Foundation
Brisbin Brook Beynon, Architects
CamberView Partners
Carol B. Smith Memorial Golf Fund
Mr. and Mrs. Richard L. Chadakoff
Charles and Margaret Levin Family
Foundation, Inc.
Cisco Systems, Inc.
Citigroup Payment Services
Clare Rose Foundation, Inc.
Connect One
Creative Bath Products, Inc.
Croatian American Charitable
Foundation, Inc.
Ms. Mary C. Dix
D-Link Systems, Inc.
Mr. and Mrs. Lawrence J. Dolan
Donatic
Dorothy “Dot” Robelen Memorial Fund
Mr. and Mrs. Eric Dusansky
Egon Zehnder International, Inc.
Dr. Joan Egrie
Elaine Levy Ordower Foundation
Ms. Debbie Elder
Entertainment Industry Foundation
EPIQ Systems, Inc.
Estate of Helen Weaver
Estate of I. Edward Picker
Estate of Suzanne Rapier
Fadeaway Records
Richard and Mary Felix
Charlotte and Jeremy Fletcher
Forchelli, Curto, Deegan, Schwartz,
Mineo & Terrana
Frank J. Antun Foundation
Mr. Gerald Frankel
Mr. and Mrs. Ronald Frankel
Mr. and Mrs. Ross Frankel
Genentech, Inc.
Gerstner Family Foundation
Mr. Zale Glauberman
Go With Courage, Inc.
Goldman, Sachs & Co.
Mr. and Mrs. Steven Goodman
Guggenheim Partners
Mr. Michael J. Halperin and Family
Mr. Roger Hathaway
Haymakers for Hope, Inc.
HBO
Houlihan Lokey
Howard Shapiro Memorial Fund
Laura and Brian Hull
IBM Corporation
IBM Employee Charitable Contribution
Campaign
iHeart Media
J.T. Hobby Jr. Endowment Fund
John Crain Kunkel Foundation
Kansys, Inc.
Kasowitz, Benson, Torres & Friedman LLP
Mrs. Marilyn Kasperick
Kelley Drye & Warren LLP
Mr. Kerry J. Kirby
Mr. Howard M. Krams
Lawton Adams Construction
Lenovo
Lightpath
Luau For Pancreatic Cancer
Lydia K. Feidler Charitable Trust
Martha Washington Straus-Harry H.
Straus Foundation, Inc.
Mr. and Mrs. Bruce Martin
Max and Sunny Howard Memorial
Foundation
MediaLink
Michael Abelon Memorial Foundation Inc.
Mr. and Mrs. Stephen E. Milstein
Miranda Fund
Morgan Stanley
MRV Optical Communications Systems
MUFG
Rafal Murczek
National Hockey League
NetScout Systems, Inc.
Network For Good
Mr. Steve Novenstein
Mr. Jeffrey Paraschac
PHD Network
Mr. and Mrs. Neil Pirozzi
Mr. and Mrs. Fred Poses
Mr. Andrew Prekopa
Mrs. F.F. Randolph Jr.
Rensselaer Honda’s Tom Gorman
Memorial Golf Outing
Mr. Donald M. Robelen
Russell & Katherine Hawken Foundation
RVM Enterprises, Inc.
Sagemcom
Mr. and Mrs. David E. Salmanson
Sandvine
Sandy Alexander
Ms. Patricia Schwarz
SCI Architects PC
Scotia Capital
Scripps Networks Interactive
SevOne, Inc.
Shostak Charitable Fund
Mrs. Judith Siegfried
Sloane & Company
Stanley Shalom Zielony Foundation
Dr. and Mrs. Mark R. Sultan
Mr. and Mrs. Daniel S. Sundheim
Sutherland Global Services
TD Securities (USA) Inc.
The Brooklyn Brothers LLC
The Ergonomic Group
The Hildenbrand Family Foundation
The Jacqueline Jackson Charitable
Account
The John G. Bolos Charitable Gift Fund
The Maria Young Memorial Fund
The MaryAnn and Gordon Rich Family
Charitable Fund
The Paul B. Greetin and Beryl S. Greetin
Foundation, Inc.
The Peter Grosslight Memorial Fund
The Robert & Lynne Grossman Family
Foundation
The Robert and Marion Schamann
Brozowski Foundation
The Sandra Atlas Bass and Edythe &
Sol G. Atlas Fund, Inc.
The Schwartz Family Foundation
The Spionkop Charitable Trust
The West Endowment
Tishman Speyer
Tom's Cure Pancreatic Cancer
Foundation
Truist
Mr. Robert S. Trump
Turner Broadcasting System, Inc.
UBS Financial Services, Inc.
Univision Communications
Ms. Courtney C. Van Auken
Joseph Kellard
The Mark Abrams Memorial Foundation
The Perelman Family Foundation, Inc.
The Peter Grosslight Memorial Fund
The Ralph C. Marcove Cancer Research
Fund, Inc.
The Richard E. Capri Foundation
The Robert & Lynne Grossman Family
Foundation
The Sandra Atlas Bass and Edythe &
Sol G. Atlas Fund, Inc.
The Weinstein Company
The William H. Isacoff, M.D. Research
Foundation
Thomasville Home Furnishings Metro NY
Time Warner, Inc.
Ben Asen
Sloane & Company
Stephen & Mary Birch Foundation
Sullivan & Cromwell LLP
Sun Microsystems
The Antoinette E. ("Mimi") & Herman
Boehm Foundation
The Benjamin Neuhausen Fund for
Pancreatic Cancer Research
The Bernice and Milton Stern
Foundation
The Harry T. Barbaris, M.D.
Memorial Fund
The Lefkofsky Foundation
The Mancheski Foundation, Inc.
The Marc Haas Foundation
VeEX Inc.
VMware Foundation
W.L. Landau Ethan Allen
Mr. and Mrs. Timothy J. Walsh
Mrs. Traci A. Weaver
Mr. and Mrs. Mark Weinstein
West Haven, CT Elks Lodge #1537
Hope and Gavin Wolfe
The Wolf Family
Mr. and Mrs. Chuck Yablon
Mrs. Monica Yandow
Andrea's Adventure
Apex Systems Inc
Mr. Joseph L. Arena
Mr. Lawrence T. Babbio
Bahnik Foundation, Inc.
Bank of America Charitable Gift Fund
Employee Giving
Mr. Joel Barnett
Mrs. Evelyn Barrow
Battelle Memorial Institute
Becker Harrow
Bicitis Group, Inc.
Ms. Susan Bick
Billy Webber Memorial Fund, Inc.
Mr. and Mrs. Richard Blomquist
Bloomberg TV
Boas Family Fund
Mr. Robert M. Bortell
Brian McGovern Memorial Golf
Tournament
Mr. and Mrs. Tom Burnett
Carol & Jack Kline Fund
Mrs. Carolann Catalogne
Mr. Robert B. Catell
Century Bank
Ms. Alana Clegg
Clifford Chance US LLP
Mr. Howard Cohen and Family
Mr. and Mrs. Douglas Cooper
Ms. Mary Ann Crutchlow
Mr. and Mrs. Gary Damast
Davis Wright Tremaine LLP
Mr. Thomas F. DeGrazia
Mr. and Mrs. Michael S. Dernburg
Dreamline
DSW Inc.
Long Valley Village Association
Loren Findorak Memorial Golf Outing
Ms. Rosalind Massow Luger
Mr. and Mrs. Andrew Lustgarten
Magda and Edward Bleier/Dana
Foundation
Marino Family Charitable Foundation, Inc.
Mark and Gayle Lerch Family Foundation
Maureen Data Systems, Inc.
Ms. Christa Meinzinger
Mr. Richard Melchner and Family
Mr. Don Middleberg
Mrs. Diane Miller and Family
Ms. Phyllis W. Miller
Mohegan Sun
Mr. and Mrs. Craig Moore
Mr. Stuart M. Morgan and Family
New York Thoroughbred Horsemen’s
Association, Inc.
Nokia Siemens Networks
Ms. Heidi J. Nolte
Omega Fi
Oracle
Pat Hall Management Group, Inc.
Mr. Doniel Perl
Phoenix Communications
Pine Hollow Charity Fund, Inc.
Ms. Lynn G. Platzner and Family
Mr. and Mrs. Hy Portnoy and Family
Mr. John J. Powers
PPC Broadband, Inc.
Mr. and Mrs. Salvatore J. Pranzo
and Family
Property Resources Corporation
Proskauer Rose, LLP
R.F.E., Inc.
Mr. and Mrs. Gil Raviv
Ms. Dolores Riordan
Roberta and Gary Fisher Charitable Fund
Mrs. Andrea Rosenfield and Family
Mr. James Rowley
RSU PayFac
Schenck, Price, Smith & King LLP
Mrs. Anne Schnesel
Score For The Cure in Pennington, NJ
Scott and Susan Davidson Foundation, Inc.
Sherry Shumaker Memorial Fund
Siena Engineering Group, Inc.
The Silvestrone Family
Dr. Hilma M. Yu and Mr. Anthony M. Sola
Mr. and Mrs. Laurence Sperry
SportsNet New York
Starz Entertainment
Dr. Zelig Steinberg and Mrs. Pamela J.
Steinberg
Sterne, Kessler, Goldstein & Fox PLLC
Stop & Stor Charitable Fund
Mrs. Stephanie F. Strauchen
Suntrust Robinson Humphrey
Mr. Martin E. Tanzer and Family
Team Krause
Technology Solutions, Inc.
TEK Systems
The Gettinger Family Foundation
BENEFACTOR
$2,500 - $4,999
58A JVD Industries, Ltd.
A. J. Bart & Sons
Mr. and Mrs. Josh Aaronson
Mr. and Mrs. Neil Aaronson
Mr. Laurence J. Abzug
Mr. Howard Adler
Mr. Darel C. Agresta
AIG Matching Gifts Program
Ms. Lynn Allen
AmazonSmile Foundation
Andrea Anastasio Charitable Fund
Ancient Order of Hibernians Div. # 2
Anything For A Friend Foundation
Mrs. Nancy Armstrong
Arthur J. Finkelstein & Associates, Inc.
Baker & McKenzie LLP
Ms. Martha G. Bannerman
Bath Authority, LLC
Mr. and Mrs. Paul Bergman
Mr. Jay D. Bienstock and Family
Mrs. Phyllis Bilus
BNY Mellon Wealth Management
Ms. Linda Boss
Ms. Taryn Bostjancic
Mr. Lawrence Botel
Brown Rudnick
BTIG, LLC
Mr. Chris Buonanno
Mr. Dennis Burt
Ms. Sara L. Cahill
Cancer Treatment Centers of America Eastern Regional Medical Center
Canter For The Cure
Cellini Charitable Foundation, Inc.
Mr. Gary A. Chanowitz
Charles A. Dailey Foundation
Classic Audi
Mr. and Mrs. Laurence J. Cohen
Mr. Peter Cohen
Dr. and Mrs. Wayne T. Cohen and Family
Ms. Wendy Cohen
Ms. Donna M. Coleman
Competition Dynamics, Inc.
Contec Holdings, Ltd.
Cooper & Schall, P.C.
Mr. and Mrs. Stephen Corman
Credit Suisse First Boston
CustomInk LLC
Mr. and Mrs. Jeff Danker
Mr. and Mrs. Peter Desmond
Deutsche Bank Americas Foundation
Matching Gifts Program
Donnelly Mechanical Corp.
Mr. and Mrs. Adam Donner
Douglas Elliman Real Estate
DST Output
E R Bane Trust
The Ebertz Family
Mr. Scott Eichel
Espalier Global
Estate of Rita Cristofani
Evening Out, Inc.
EyeKrafters Medical Optics, P.C.
F5 Networks
Five Prime Therapeutics, Inc.
Mr. Frank Fortino
Ms. Helene Fortunoff
Ms. Jacqualyn A. Fouse
Mr. Andy Frank
Mr. Charles Frankel
Anita Dann Friedman
Friends of John V. Duffy
Fross Zelnick Lehrman & Zissu, P.C.
Fusion Media
Mr. and Mrs. Gregory Gannon
Mr. Lawrence J. Gannon
Mr. John J. Garthoeffner
Mr. and Mrs. Dave Girolamo
Ms. Gail Gittleson
Ms. Anne F. Glauber
Glen Oaks Club
Barbara and Abdel Ghafir
Mr. Michael Greengarten
Greenwich Hospital
H2 Consulting, Inc.
Ms. Gail F. Harms
Hauser's Truck Service
Dr. Jason T. Heckman
Mr. Harvey R. Heller
Mr. Merrit Heminway
Hershey Family Fund
Mrs. Lauri Hidalgo and Family
Hogan Lovells US LLP
Home Depot Foundation Matching Gifts
Honorable Golfers of 2015 Sycamore
Tournament
Mrs. Inge Horn
Mrs. Loretta E. Howard
Ms. Amy Hunter
ICRAVE, LLC
iN DEMAND
J. Horowitz and E. Hardin Fund
Jack Haley Memorial Fund
Ms. Beverly S. Jacobs
Mr. Perry Jacobson
Joseph F. Stein Family Foundation, Inc.
Juniper Networks
Dr. Frank M. Kamer
Mrs. Louise Kaminow and Family
Mr. Jeffrey Kan
Mr. Marc Karetsky
Mrs. Dolores Karp
Mr. Christopher Kete and Ms. Tiffany
George-Kete
Ms. Nancy Kieffer
Mr. and Mrs. Ron Kisner
Mr. and Mrs. Brad Kitchens
Mrs. Kathy Klauda
Knights of Columbus No. 5989
Kobre & Kim LLP
Nicole and Stuart Kovensky
Mrs. Yolanda J. Kunz
The Kurman Family
Mr. Douglas E. Lantz
Mr. and Mrs. Michael E. Laub
Laurie Milotte Memorial Fund
Ms. Marianne Lazarou
Mr. Brian D. Leaghty
Mrs. Elizabeth P. Levengood
Mrs. Renee Lockhart
LogicPrep
Photo courtesy of the Towle Family
Barbara Trainor
Mr. and Mrs. Roger Abramson
Adam Levine Productions
Alliantie Technical Group, Inc
Ambrosio & Bellotti Charitable
Foundation Inc.
American Express Foundation Employee
Gift & Matching Program
Dun & Bradstreet
Edward Darman Co., L.P.
Estate of Doris Schumer
Estate of Roberta Coppola
Farrell Fritz, P.C.
Fathom Communications LLC
Fifth Avenue of L.I. Realty Association
Foremost Footwear LLC
Ms. Ruth Fortunoff-Cooper
Jennie Fortunoff and Andrew Chonofsky
Fox Networks
Fox News Channel
Mr. Sidney Friedman
GE Foundation Matching Gifts Program
Gene Toth Memorial Fund
Giuseppe Nigro Home Lodge 2234
Gleason Family Foundation, Inc.
Mr. Keith Goggin
Goldman Sachs Gives
Goldman, Sachs & Co. Matching Gift
Program
Mrs. Bernice L. Gotlieb
Gracenote
Ms. Courtney Granville and Mr. Daniel
Rosenthal
Ms. Rona M. Guidone
Mr. Jeffrey Gural
John and Julie Hamre
Hanover Park High School
Harkavy-Mack Foundation
Haynes and Boone, LLP
Mrs. Deborah Heidecorn and Family
Heritage
High Point Utilities
Mrs. Debi Hills and Family
Mr. Ronald Hohmann
Horwith Trucks, Inc.
Insurance Auto
Integrated Broadband Services, Inc.
Intex Solutions, Inc.
Irwin Chafetz Family Charitable Trust
Mr. and Mrs. Jon Iwata
Mrs. Sylvia Jacobs and Family
James & Eileen Bruce Foundation
Jaros Baum Bolles Consulting Engineers
Jayco
JFK Air Cargo Association, Inc.
Joann Weber Charitable Fund of
the Greater Lowell Community
Foundation
Johnson & Johnson Matching Gifts
Program & Employee Funds
Mr. and Mrs. Philip Johnson
Mr. and Mrs. Michael Kabat
Mr. and Mrs. Armenag Kalaydjian
Mrs. Carrie Kelley
Mr. Scott W. Kilrea
Mr. and Mrs. Kenneth Klein
Ms. Mary Klim
Mr. Patrick E. Law
Mr. and Mrs. Joe Lawrence
Liberty Mutual Employee & Matching
Gift Program
Tobey Lipschitz
Joseph Kellard
BRONZE CIRCLE
$5,000- $9,999
Mrs. Marie Lopez
Lord & Taylor
Ms. Helen Lowenstein
Mr. Michael Mackey
Mrs. Chrissy M. MacTaggart
Mrs. Thane Malison
Mayer Brown LLP
Mr. Doug McDaniel
Melvin R. Goodes Family Foundation
Merck Partnership For Giving
Microsoft Matching Gifts Program
Ms. Jean Miller
Mr. Max Miller
Mr. Paul W. Moderson
Montauk Sports, Inc.
Montefiore Health System
Mr. Quinn Montgomery
Ms. Jo Ellen Moore
Moritt Hock & Hamroff LLP
Mountain Empire Oil Company
Ben Asen
PATRON
$1,000 - $2,499
Mr. Jeffrey Ross
Mr. Matthew Schwartz
Sellers Publishing, Inc.
Mr. and Mrs. Steven E. Sesterhenn
Mr. Bradley Setser
F. Shanks
Mr. Thomas Shapiro
Mr. Bradley N. Shippert
Shoreline Brewery & Restaurant
Dr. and Mrs. Anthony Sifonios
Sirius America Insurance Company
Mrs. Abby Smith
Steel Equities
Mr. Mark J. Stein
Steiner Sports Memorabilia, Inc.
Mr. Robert Stone
Mr. Joseph M. Sullivan
The Aboodi & Hoffman Families
The Frank J. Romano Foundation, Inc.
The Amy Udell-Mauskopf Family
538 Driggs Avenue Corporation
A & D Restorations, LLC
A.C. Israel Foundation
Ms. Solange Abbate
Mr. and Mrs. Milton B. Adams
Advanced Fiber Works, Inc.
Advent, Inc.
Aetna
Mr. Donald J. Aharonian
Albany Gastroenterology Consultants,
PLLC
Mr. and Mrs. Andrew Alberti
Ms. Kiersten Albrecht and Family
Mr. and Mrs. Havard Albright
Mr. and Mrs. David Albritton
All Phase Construction Group, Inc.
Alliance Bernstein LP
Mr. and Mrs. Donald Allman
Alma DDB
American Metals Supply Co., Inc.
AmWINS Brokerage
Analysis Research Planning Corp.
Ms. Quinta E. Andersen
Annelise Peterson Winter & David S.
Winter
Anthem Sports and Entertainment Corp.
Mr. Graham Anthony
AON Risk Services, Inc. of NY
ARCCA, Inc.
Mr. Robert Arconti
Arlindo and Evelyn Jorge Family Trust
Armrod Charitable Foundation
Mr. and Mrs. David Arnow
Artemis Gallery
Artexture
Mr. Anthony Arturi and Family
Mr. Veeraraghavan Arun
Mrs. Margaret Asselin
AT&T United Way/Employee Giving
Campaign
Mr. and Mrs. Edward C. Atwood
ATX Networks
Mr. B. Reuben Auspitz and Ms. Dawn K.
Good Elk
William and Augusta Austin
AXA Foundation
Mr. and Mrs. Alan Azralon
Bacchus Importers, Ltd.
Mr. Brian Bae
Mr. Robert Bagdorf
Bank of America Foundation
Matching Gifts
Mr. and Mrs. Steven C. Bardwil
Ms. Keri Barmak
Barnabas Health Behavorial Health Center
Mr. and Mrs. Adam Barnett
Mr. Troy Bartley
Mr. William Bassett
Mr. and Mrs. Michael E. Bauer
Mr. Dennis Bavaria
Mr. Steven Beberman
Ms. Roz-Lynn Beckenstein and Ms. Julie
Beckenstein
Ms. Ellen Becker and Mr. Howard
Hamburger
Jeffrey and Barbara Becker
Mr. Michael Becker
The Bedard Family
Bedford High School Volleyball Team
Ms. Virginia Bedford
Mr. Arthur D. Bellini
Ms. Jill Bender
Dr. and Mrs. Chester A. Bennett
Mr. Gary M. Bennett
Berdon LLP
Mrs. Lori Berisford
Mrs. Karly Berman
Mr. Douglas Bernstein
Rick and Jane Bernstein
Dr. Wendy B. Bernstein
Mr. Michael Berr
Bill and Ellen Bell
Bill Tamburro Jr. Memorial Golf
Tournament
Mr. Richard S. Birnbaum
Mr. Steven Bissonnette
Ms. Marlene Bittman and Family
Black Pearl
BlackRock Matching Gifts Program
Blechman-Morenoff Foundation, Inc.
Blue Ridge Capital, L.L.C.
Ms. Joanne Blum
Mr. and Mrs. Stuart Bobry
Mr. Mark Bodie and Ms. Kristine M. Ryan
Ms. Candice R. Bolte
The Bonde Family
Ms. Laura Boothe
Borax Paper Products, Inc.
Mr. Mitchell F. Borger
Ms. Jessica Borowick
Mr. John Boruta and Family
Dr. Harriet S. Boxer
Bob and Tammi Brady
Mr. and Mrs. John B. Brand
Ms. Margaret A. Brand
Mrs. Bernardine Brandis
Mrs. Marie Brausam
Mrs. Laura Brehmer
Bretton Woods Golf Club
BRIC-TPS, LLC
Bridgewater Associates, LP
Bristol-Myers Squibb Foundation
Broadridge Financial Solutions, Inc.
Broadridge Foundation Matching Gifts
Program
Mr. and Mrs. Mark Brosky
Mr. and Mrs. Michael J. Brown
Peter and Sandy Bruhn
Mr. Kenneth Bruley
Brut LLC
Mr. Richard A. Buchanan
Andrew and Jodi Buchbinder
Mr. and Mrs. Mitchell I. Buchbinder
Buckley Brothers, Inc.
Mr. Edward H. Budd
Budget Blinds of Ossining, NY
Mr. and Mrs. John P. Buechler
Bulldog Ventures, Ltd.
Mrs. Angela Buonocore Wilkins
Mrs. Jan L. Burch
Mrs. Gwen Burtch-White
Burton & Rose Kahn Family Foundation
Mr. Mark Byrne
Ms. Maryanne C. Byrnes
CA, Inc. Matching Gifts Program
Mr. John T. Cahill
CAK Entertainment
California Association of Health
Facilities
Mr. Ryan W. Callas
Callaway Volunteer Rescue Squad
Ms. Jo-Ann Cambareri
Cancer Treatment Centers of America Western Regional Medical Center
Mr. John T. Carey
Mrs. Hayley B. Carlson
Mr. and Mrs. Bob Carniaux
The Carnogursky Family
Mr. Douglas R. Carpenter
Ms. Boi Carpenter-Mellady
Mr. Freddy Carrano and Family
Mrs. Anne Caruso
Casa Systems, Inc.
Mr. Douglas Castoldi
Ms. Joann Catalano
Mr. and Mrs. Joseph J. Catapano
Mr. Dennis M. Caulfield
Cavallo Family Foundation
CBRE Cares
Century Mortgage Company
Ms. Shari Cerini
Mr. and Mrs. Aaron J. Chaitovsky
Ms. Andrea Chambers
Changing Our World, Inc.
Charles M. Cappellino Foundation, Inc.
Mr. Thomas Cherner and Ms. Lynn A.
Suter
Chleck Family Foundation, Inc.
Mr. William J. Christ
Mr. and Mrs. Thomas E. Christman
Chubb & Son, Inc. Matching Gifts
Program
Mrs. Susan Cicala
Mr. Thomas A. Cifardi
Circle of Hope Bracelets, Fran's Hope
Foundation
Cisco Capital
Citco Fund Services (USA), Inc.
Mr. and Mrs. Warren L. Clark
Clarkson Construction Company
Mr. Montgomery C. Cleworth
CoBank
Mr. and Mrs. John Cobb
Mrs. Sharon Cobb
Code 3 For A Cure Foundation
Mr. Jeffrey Cohen
Mr. Martin Cohen
Mr. Steven M. Cohen
Mr. Charles E. Colander
Ms. Gail Coleman
Mr. Harry A. Coleman II
Mr. William H. Coleman
Mr. Brian Colgan
Collection Bureau of the Hudson
Valley, Inc.
Ms. Valerie Colon
Mr. and Mrs. Marcel G. Comire
CommScope
Complete Leasing Systems, Inc.
Ms. Barbara Congema
Mr. Charles Connors
Mr. and Mrs. Ben Conte
Mrs. Georgia Cooper and Family
Mr. and Mrs. Bill Cooper
Mr. Jordan Copland
Ms. Loretta R. Cormier
Ms. Kim Cornell
Mrs. Maureen Cornicelli and Family
Corning Optical Communications
R. Cosentino
Ms. Linda Cote
Mr. Bob H. Cox
Credo, LLC
Mr. and Mrs. Robert Crimmins
Mr. Eric Crockett
Mr. Brian Crowley
Crown Media Family Networks
Ms. Sarah Cummings
Mr. and Ms. John J. Curley
Mrs. Pamela Currey
Mr. and Mrs. Errol Cvern
Mr. John Czajkowski
Dallastown Area Basketball Booster
Mr. Peter Dalton
Mr. and Mrs. Philip G. D'Ambrosio
Joseph Kellard
The Riese Organization
The Road Knights Auto Club, Inc.
The Thalia and George Liberatos
Foundation
The Walt Disney Company Foundation
The Weiser Philanthropic Foundation
The William and Sylvia Silberstein
Foundation, Inc.
Thrivant
Time and Again, Inc.
Mr. Alexander Tisch
Mr. Raphael Toledano
Mr. Michael Tramontano
TV Guide Network
U.S. Bank
UBS Matching & Employee Gifts Program
University of Colorado Hospital
Waldner's Business Environments
Mr. Paul W. Watson Jr.
Mrs. Carol Whalen and Family
William Goldberg Diamond Corp.
Ms. Megan Wisdom
Mr. Larry J. Wyman
Dr. and Mrs. Charles Zugerman
Ms. Karen Zupko
ZwillGen PLLC
Mr. Michael Damken
Mr. Michael P. Damm
Mr. Lyell Dampeer
Danella Line Services Co., Inc.
Ms. Roberta Danza
Daphne I. Panagotacos M.D. Inc.
Mr. Rick Dastin
Davidoff Hutcher & Citron LLP
Mr. Thomas Deese
Mrs. Naima Dennis
Dentalle, Inc.
Dr. Kumar Desai
Mr. Adam DeSanctis
Mr. and Mrs. Harris Diamond
Mr. and Mrs. Randy J. Diamond
and Family
Mr. John DiDomenico
Ms. Jodilynn DiPiazza
Discover Financial Services
Doctors Express
Mr. David M. Dolan
Ms. Lorna T. Donatone
Mrs. Louise Donnelly
Mr. and Mrs. Herbert C. Donner
Ms. Sandra L. Dosick
Mr. Stephen M. Dowicz
Mr. Vincent B. Dowling
Mr. John P. Dries
Dropbox
Mrs. Katherine Druley-Herron
Dunkin’ Donuts of North Grafton, MA
Barbara Trainor
Ms. Catherine R. Nathan
Mr. and Mrs. J. Michael Nolan
Old Westbury Golf & Country Club
Mr. and Mrs. Kirk Oliver
Mrs. Erika L. Padgett
Patricia Armstrong Dressler Foundation
Mr. William G. Paullin
Perception Research Services Inc.
Perfect Vision Manufacturing Inc.
Phillips-Van Heusen Foundation, Inc.
Mr. Jack R. Pine
Mr. and Mrs. Jeffrey L. Pliskin
Price Family Fund
Dr. Nathan T. Pruitt
Punch Out Pancreatic Cancer
Quan, LLC
RAD Communications
Ms. Laurice Rahme
Mr. Henry P. Randall IV
Ms. Georgia Renne
Mr. Gerry M. Ritterman
Mrs. Eve K. Robinson and Mr. Joshua
Wiener
Rock Hill Golf & Country Club
Mrs. Cheryl Ross and Family
Mrs. Stacey Evans
Everyday Hero
F & F Hardware and Supply, Inc.
Ms. Andrea Fairhurst
Mr. Martin G. Farber
Dr. and Mrs. David Fastenberg
Mrs. Rozanne T. Faulkner
Mr. Charles M. Fegley
Drs. Randall and Sheryl Feingold
Mr. George Fekete
Mr. Greg Feldman
Mr. Jonathan Feldman
Mr. and Mrs. Ross Feldman
Mr. William Felton
Ms. Phyllis Fenster
Mr. Joseph Feshbach
Neal and Phyllis Finkelman
Mr. Steven Finkelstein
FirstGiving
Dr. and Mrs. Joel Fischer and Family
Mr. Mark Fischer
Mrs. Francine Flamino
Ms. Wendy Flanagan
Mr. and Mrs. Rob Fleder
Mr. Wayne S. Flick
Mr. Michael Flood
Foley & Lardner LLP
Charles A. Forma, Esq.
Timothy Foster
FosterThomas, Inc.
Mrs. Sandra Fout
Foxwoods Resort Casino
Mr. Bruce D. Frank
Mrs. Nina Frankel
Mr. Carl Frascogna
Mr. and Mrs. Avram C. Freedberg
Mr. Walter Freeman
Friedberg Pinkas PLLC
Mr. Andrew H. Friedman
Mr. Edward A. Friedman
Mrs. Elizabeth Friedman
Friends of Stu Freed
Mr. and Mrs. Tom Fullerton
Mr. Tiberio Furtado
Mr. and Mrs. Matthew Gaier
Mr. and Mrs. Kenneth Gamble
Joe and Mary Gardill
Mr. Mark Garten
Mr. John M. Gaynor
Dr. Clyde Generoso
Geraldine R. Dodge Foundation, Inc.
Mr. Kenneth Gideon
Mr. Bruce Gifford
Ms. Adrienne Gilberg
Mr. and Mrs. Cliff Gilbert-Lurie
Mr. Josh Gillon and Family
Giomare Group LLC
Mrs. Geri Giorgio
Mr. Jay T. Glassman
Mr. and Mrs. Marc Glenn
Sam and Emily Glick
Mrs. Katherine Gohdes
Mrs. Sherry Gold
Ms. Sarah L. Gold
Jesse A. Goldberg
Mr. and Mrs. Arthur Goldfrank
Ms. Katja Goldman
Dr. Lawrence Goldman
The Goldsmith Family
Mrs. Danielle Goldstein
Ms. Meryl S. Goldstein
Richard & Candy Goldstein
Ms. Shirley I. Goldstein
Mr. William Goldstein
Golf Tournament at Pine Hills
Mr. Ernest Gomez
Mr. and Mrs. Russ A. Goodman
Ms. Kristin M. Gorman
Mr. Peter Gormley
Mr. and Mrs. Bruce Gorsky
Mrs. Jackie Gosin
Mr. and Mrs. Peter Gottlieb
Mr. and Mrs. Peter Goulding
The Gray Family
Greater Saint Louis Community
Foundation
Mr. Mark Greb and Family
Green Valley Cooling & Heating, Inc.
Ms. Madge Greenblatt
Joseph L. Greene and Family
Mrs. Pamela W. Greenstein
Mr. and Mrs. Bruce Greenwald
Mr. and Mrs. Bryan Greenwald
Ms. Jane Griffith
Ms. Marie “Meg” Griggs-O’Connor
Mr. Marc Grill
Mrs. Regina Grim
Ms. Terry Groll
Ms. Marlene Gromis
Joan and Stuart Gross
Groupon
Mr. Bernard Groveman
Mr. and Mrs. Abe Gruenwald
Mrs. Annelies Guglberger
Mr. Cole Gunter
Dr. Michael Guttenberg
Hackensack University Medical Center
Ms. Teresa H. Hacunda
Mr. Thomas E. Haeckel
Ms. Margaret L. Hagen
Mr. Frank J. Hague IV
Mr. Drew Hahn
Mr. and Mrs. Peter R. Haje
Mr. Patrick Hall
Mr. Thomas A. Hall
Mr. and Mrs. Steve Hammerman
Mrs. Martha Handler
Ms. Elizabeth Hansen
Mr. Brent D. Hardgrave
Dr. John A. Harman
Harmonic, Inc.
Ms. Pamela M. Harper
Mrs. Ikeyona Harvey-Jones
Mr. Jeffrey K. Hass
Dr. Caryn Hasselbring
Haugebak Construction Co.
Mrs. Karen Hawes and Family
Mr. Spencer B. Hays
Mr. Christopher B. Hayward
Mr. Steve Heckler
Mr. Raymond Hedaya
Mr. Edward Heffner
Mr. Stanley Heilbronn
Hemisphere Media Group
Ms. Kristi Henslin
Mr. and Mrs. Paul Herbert
Ms. Ilissa A. Herskowitz
Ms. Cheryl Heuring
Mr. Alan Hinds
Hisco
Mr. and Mrs. Jonathan Hitchcock
Mr. Jordan Hoch
Mrs. Susan C. Hoddinott Hills
Mr. and Mrs. Richard Hoffer
Hoffman Enterprises
Ms. Victoria Hohmann
Jim and Judy Hoke and Family
Ms. Elizabeth E. Holle
Mr. Marc Holt
HomeServe
Mr. Freddy Hondo
Ms. Terry Horowit
Mr. and Mrs. Craig M. Horowitz
Mr. Troy D. Horstman
Ms. Mary Ann Horvath
Mr. Michael F. Horwith and Family
Mrs. Joyce G. Houlihan
Mr. Robert J. Hrebek
Mr. Frank N. Hughes
Ms. Ingrid Hughes
Humanscale
Mr. Ed Y. Hung
Mr. Denis Hurley
Hylan Datacom & Electrical, Inc.
IDI Gazely
Mrs. Amy Iles
Immaculate Heart Academy
Independent Investment Group LLC
Industrial Cooling
Infosys Limited
ION Computer Systems
Iowa Classic Horse Show
Mr. and Mrs. John M. Ivanoski
J. Roger Newstedt, M.D. Family Fund
Jackel Capital Inc.
Dr. Mitchel Jacobs
Ms. Sharon H. Jacquet
Mr. Bruce Jaffe
Mrs. Linda M. Jayne
Jeff Horstman Golf Tournament
Jemcap LLC
Mr. John B. Jenkins
Mr. Keith Jepsen and Ms. Kathleen Dore
Jerrold A. Salmanson Foundation
Mr. and Mrs. Daryel L. Jesperson
Mr. Manish Jhanji
Jim Alberto Memorial Golf Classic
Joao Teixeira Memorial Fund
John Scotts Inc
Mrs. Jaqueline M. Johns
Mr. Leonard A. Johnson
Ms. Shirley K. Johnson
Mr. and Mrs. Thad Johnson
Mr. and Mrs. William Jordan
JPMorgan Chase & Co. Foundation
Dr. Tina Jupiter
JustGive.org
K&L Gates LLP
Ms. Maxine Kabol
Mr. Alex Kahen
Mr. and Mrs. Bahman Kamali
Mr. Harold N. Kamine
Mr. Gary M. Karlitz
Ms. Daryl Karter
Mr. Burton R. Kassell
Mr. Gary Katcher
Mr. Steven Katz
Mr. Ronald A. Kaye
Mrs. Amy Kealey
Keith J. Lamphere - DBA Lamphere’s
Truck Parts
Kenley Realty Company
Mrs. Suzanne N. Kennedy
Mr. William J. Kenney
Mr. Alan Kessler
Mr. and Mrs. Jim Kewley
Ted and Laura Kiesewetter
Mr. William Kilinskas
Mr. Michael Kimak
Mr. Stephen Kincade
Kirkland & Ellis Foundation
Mr. Bradford L. Klein
Mrs. Sandi Klein
Mr. and Mrs. George M. Klett
Ms. Elizabeth Kline
Ms. Nancy Kline
Mr. Thomas S. Knowles
Mrs. Barbara R. Kokot
Ms. Agnes E. Kovacs
Mr. Ira Kovel
KPMG Community Giving Campaign
The Kraft Family
Mr. William Kramer
Mr. Joseph Krasovec
Mr. and Mrs. Alan J. Krauss
Mr. and Mrs. Lawrence Krulik
Mr. Richard E. Kubanik
Ms. Alice C. Kuechler
Mr. Josh Kulberg
Mr. and Mrs. Tomislav Kundic
Ms. Beth R. Kurlander
Kurtz Family Foundation
Mr. Eiichiro Kuwana
Mrs. Corey Labadorf
LABS, Inc.
Ms. Carol L. Lace
Ms. Michele LaFave
Ms. Belinda Lai
Mr. Thomas Lamberti
Mrs. Margaret Lamoreaux
Mr. and Mrs. Stewart Lande
The Laub Family
Mr. John Laxmi
Mr. Wesley R. Leach
The Learman Family
Dr. Irwin J. Lebish
Legend Shotokan Karate LLC
Lehigh Valley Health Network
Mr. and Mrs. Alan Leifer and Family
Leonard Park Wines & Spirits, LLC
Mr. Ronald L. Lerman
Mr. and Mrs. Scott Lerner
Dr. Philip Lesorgen
Level 3 Communications
Mr. and Mrs. David Levien
Mr. Steven A. Levine
Levine Sullivan Koch & Schulz LLP
Mr. Benjamin Levy
Ms. Ellen F. Levy
Mrs. Lenore S. Lewis and Family
LFP Broadcasting, LLC
Mr. A. Mitti Liebersohn
Lightower Fiber Networks
Mrs. Maria Lima
Ms. Megan Lineberger
LinkedIn Matching Gifts Program
Ms. Luciana Lino
Mr. Aaron Linsky
Mr. Thomas Lint
Mr. David Liola
Michael and Chris Llewellyn
Paul and Elizabeth Loosmann
Mr. Steven Loranger
Ms. Jennifer Lorenzen
Mr. Stuart H. Lubow
Barry and Deborah Lucas
Lucky's Real Tomatoes
Mr. James MacGregor
Ms. Betsy Mackey
Ms. Cynthia MacKinnon
Macy's and Bloomingdale’s Foundation
Mr. and Mrs. Richard D. Mager
The Magno Family
Mr. Brian K. Maier
Mrs. Jane A. Malison
Mancini Duffy
Mr. David J. Maniaci
Mr. and Mrs. Martin J. Mannion
Ms. Patricia Marcus Curtis
Mr. Jeffrey Marcus
Michael, Robyn, Annie and Abby Marcus
Ms. Noreen Marcus
Mr. Robert Marcus
Mr. Steven Marentis
Dr. Gabrielle Marshall-Salomon
Mr. and Mrs. Daniel Marszalek
Mr. Bill Matthews
Max B. Cohn Family Foundation
Mayfair Power Systems, Inc.
Mr. Joseph D. Mayo III
Mr. Joseph Mazzone
Mr. Keenan McBride
Mr. Kevin McCarthy
Mrs. Mary E. McGinn and Family
Mr. and Mrs. Thomas E. McGrath
Ms. Katie McIntosh
Mr. and Mrs. Edward E. McIntyre
Mr. and Mrs. Michael McKeever
McKenney's, Inc.
Ms. Shirley J. McRae
University of Michigan
Ben Asen
Dr. Ellen J. Dutta
EARS To You - Disney VoluntEARS
Community Fund
East Penn Manufacturing Co., Inc.
Ms. Elaine Eaton
Mrs. Donna E. Edwards
Efficient Combustion & Cooling
Corporation
Ms. Meridith Egyes
Roger and Sondra Eichel
Mr. and Mrs. Bob Eisele
Mr. Lewis M. Eisenberg
Mr. Robert Eisman
Mr. Martin Elias
Elizabeth and Oliver Stanton Foundation
Mrs. Daryl Elliott
Mr. Fred K. Ellis
Elmwood Charity Fund, Inc.
Mr. Curtis A. Elsbernd
Empire National Bank
Empire Properties Management, LLC
Ennead Architects LLP
Ms. Joyce E. Erony
Ms. Nancy J. Eschedor
Estate of Jeffrey Newman
Joseph Kellard
Ms. Melissa R. Mirabile
Mrs. Millie A. Mitchell
Mr. William Mitchell
MLB Network
Mr. and Mrs. John H. Moehling
Mrs. Michelle Monte
Mr. and Mrs. Michael Monteleone
Ms. Karen Moore
Mr. Thomas Moore
Ms. Brooke Morgan
Mr. Scott Morgan
Morgan Stanley Smith Barney Foundation
Morgan Stanley Foundation - Employee
Giving Program
Mori Lee
Ms. Linda Joy Morris
Mrs. Linda Moslow
Mrs. Anita E. Motkowski
Muchnick Family Foundation
Matthew and Louise Mueller
Dr. Nancy Mueller
Ms. Jane Muhrcke
Mrs. Yvette Mulderry
Mr. George Mullen and Family
Mulligan Security Corporation
Mrs. Mary M. Mulvihill
Ms. Lynn Murcott
Murphy & Fahy Construction Co., Inc.
Ms. Ann L. Murphy
Mrs. Ellen Murphy
Music Choice
Muzio Family Foundation
Ms. Deborah Nadel
Ms. Lauren Naru
National Penn Bancshares, Inc.
Mr. William C. Neal
Netrovert Software Inc.
Newell Rubbermaid
Jessica and Michael Newshel
Mr. Roy Niederhoffer
Mrs. Elin Nierenberg
Ms. Pamela Noble
Mr. David Nochimson
Ms. Sue Norris
North American Wireless Solutions of
NY LLC
Northwell Health
Mr. Donald R. Novicky Sr.
Nutcracker Technology
Mr. William G. O'Callaghan
Dr. Allyson J. Ocean
Och-Ziff Capital Management Matching
Gifts Program
Mr. and Mrs. James O'Connor
Peter and Debra O'Connor
Ms. Sarah Oey
Offshore Sailing School
Mr. Melvin N. Oftedahl
Mr. Lionel Ohayon
Mr. Christopher L. Oleaga
Ms. Deborah J. Olita
Omnicom Management, Inc.
Mr. Steven Orbuch
Mr. Patrick Ortman
Mr. Michael L. O'Shea Sr.
Outdoor Channel
Ms. Jacqueline Page
Mrs. Marilyn J. Palmer
Panas Volleyball Booster Club
Paramus Associates, LP
Mrs. Anna Paret
Mr. Sherin Parikh
Mr. and Mrs. Gregory Park
Mr. Scott Parker
Participant Channel, Inc.
Mr. Hal Parton
Pastime Athletic & Social Club, Inc.
Mr. Bill Patellos
Ms. Linda Lee Paulsen
Dr. Judy I. Pawlusiow
PCI Group Inc.
Mr. Morris B. Pearl
Mrs. Marci Pere
Ms. Roslyn Persky
Mr. John Pessolano
Mr. Adam Peterson
Mrs. Maureen Peterson
Mr. Andrew Petitti
Mrs. Beatrice Peyser
Pfizer Foundation Matching Gifts
Program
PHH Corporation
Phil & Anita Gauer
Mr. Tony Pianese
Ms. Victoria Pierce
Mr. Michael Komichak and Ms. Daria A.
Pishko Komichak
Pj Callahan Foundation, Inc.
Playboy Plus
Mr. Les Poinelli
Mr. and Mrs. Michael Pomeranc
Mr. Andy Pon
Ms. Julia Pon
Mr. Marc S. Porter
Mr. Kirk Pothos
Ms. Mary Frances Potts
Mr. Louis G. Poulin
Mr. Andrew Poulos Sr.
Powerhouse Paving
Mrs. Kirstin Powers
Mr. and Mrs. Mark J. Prak
Irwin and Audra Press
Ms. Lynn Pressler
Mr. and Mrs. Barry Prevor
Mr. Steven Price
Mr. and Mrs. Gary L. Prior
Pro Tools
Dr. and Mrs. Angelo J. Procaccino
Project One, Inc.
Pronto Pizza and Pasta
Mrs. Gail Propp
Mrs. Lynn Przydrozny
Pullman & Comley, LLC
Pure Play Broadcasting
Mrs. Ruth Queen
Mr. William Quigley
Mr. and Mrs. David J. Rabinowitz
and Family
Radiant Logic
Mr. and Mrs. Richard Radutzky
Mr. Milton Ragusa
Dr. Veena Rai
Raising Hope for Others
Mrs. Staci Ramachandran
Dr. Louise Ramm
Mr. Harvey Rappaport
Mr. and Mrs. Steven Rathgaber
Mr. Bob Razem
Mr. and Mrs. Steve Realbuto
Ms. Portia T. Redfield
Dr. Lauren Redler
ReelzChannel
Mr. and Mrs. Timothy Reis
Garrett Reisman
Mr. and Mrs. Carl and Anna Reisner
Mrs. Stacey Remnitz and Family
Photo courtesy of Tara Shanes-Hernandez
Ms. Ellen L. Meckler
Mrs. Josephine A. Meilan
Lt. General (Ret.) and Mrs. David F. Melcher
Mr. and Mrs. Stephen G. Melidones
Mercer
Ms. Elaine Merians
Mr. Tom Messner
Metaswitch Networks
MetLife
Metropolitan Local Masters Swimming
Committee, Inc.
Metta Fund
Mr. and Mrs. Ed Meyer Jr.
Michael J. Zamkow and Sue E. Berman
Charitable Foundation
Philip and Jean Michael
Dr. Eugene A. Mickey
Mickey's Montauk Mowing, Inc.
Mid-Island Y JCC
Midlothian Optometric Center
Mr. John A. Miers
Milken Family Foundation
Millennium, The Takeda Oncology
Company Matching Gifts
Mrs. Eliza Miller
Mr. Marc Miller
Mr. Timothy Miller
Minerals Technologies
Ms. Meaghan A. Repko
Rex and Nelle Jackson Foundation
Ms. Carol A. Rhoads
Ms. Julie Riccomini
Mr. and Mrs. Edward F. Rieger
Ms. Margaret R. Riemer
Mr. Thomas Rikert
Ms. Rachel S. Ringler
Mr. George A. Rippey and Ms. Linda
Paulsen
Ritchey Family Foundation, Inc.
Riverdale Country School
Mrs. Mary Rizzo
Robert Graham Designs LLC
Robert R. McCormick Foundation
Mr. Nicholas Robinson
Ms. Roberta Robinson
Ms. Melissa L. Roeters
Mr. and Mrs. Steve Rogness and Family
Mr. Gerald Rokoff
Mrs. Dana Romanello-Flynn
Ms. Lorraine E. Rooney
Ms. Andrea Rosenberg
Ms. Lauren Rosenberg-Moffitt
Mr. Moe Rosenblum
Mr. Andrew B. Rosengard
Mrs. Marian Rosenwasser-Jordan
Mr. and Mrs. Steven Rosenzweig
Mr. Michael Ross
Mr. and Mrs. Raymond W. Ross
Rotary Club of Lexington
Mr. and Mrs. Clarence Roth III
Rovi Corporation
Mr. Andrew Rowley
Roy J. Zuckerberg Family Foundation
Mr. and Mrs. Barry Rubenstein
Ms. Jami Rubin
Mr. Kit Rudd
Ruskin Moscou Faltischek, P.C.
Mrs. Barbara Russell
Ms. Jeanne Y. Russell
Mr. Alex T. Russo
Ms. Anna M. Ryan
Mr. Peter Ryan
Safety Tire Seal
Salesforce.com Foundation Matching Gifts
Ms. Hara Salkovitz
Ms. Penny Sallinger
Mr. and Mrs. Marc Samit
Mr. Bradley Samuels
Sandpiper Fund, Inc.
Sandra's Comfort, Inc.
Mr. and Mrs. Roger W. Sant
Mr. Thomas Santiago
Mr. and Mrs. Kurt W. Saraceno
Saratoga Race Course Trainers’ Event
Ms. Mary T. Sargent
Mr. Robert and Anne Sargent
Mr. and Mrs. Andrew J. Sarno
Ms. Teresa A. Sarno
Mr. Mark Satov
Jason and Mindy Satsky
Mr. Lance Sauerteig and Ms. Wendy
Kavasin
Mr. John F. Sawyer
Saxon Associates
Mr. Stuart Schechter and Ms. Jaeyeon
Jung
Ms. Linda Schector
Schlachtenhaufen Family
Mrs. Donna Schlonski
Mrs. Lisa Schlonski and Family
Mr. John Schmidt
Mr. Donald Schneider
Mr. Kenneth M. Schneider
Ms. Lillian Schneider
Mrs. Tami Schneider
Mr. and Mrs. Michael Schock
Mr. and Mrs. Brian Schorr
Mrs. Carmen P. Schramm and Family
Schulman Family Foundation
Mr. Harvey Schulweis and Ms. Barbara
Benerofe
Schulze & Burch Biscuit Co.
Mrs. Nancy Schuman
Mr. Robert B. Schumer
Ms. J. Virginia Schurz
Mr. Peter Schwalbe
Mr. William Schwalbe
Mr. Jerome M. Schwartzman
Scottrade
Seaboard Forwarding Co., Inc.
Ms. Katherine A. Sears
Mr. Bruce Seger
Ms. P.W. Seitz
Sertex
Servcorp.
Mr. Scott Shane
Mr. and Mrs. Joel Shatles
Ms. Dawn Shell
Shell Point Retirement Community
Dr. Malini Shenava
Mr. Sunil Shenoi
Dr. Vasudeva Shenoi
Mr. Jonathan M. Sherman
Ms. Lorraine Shields
Dr. Robert D. Shlien
Mr. Joseph Shreiner
Ms. Martha Lovenheim Siegel
Mr. and Mrs. Joel Sieger
Siemens Caring Hands Foundation
Ms. Doreen M. Sigelko
Mr. Robert Silver
Ms. Regina L. Silverman
Dr. and Mrs. Douglas Simon
Dr. Karen Singer
Mrs. Linda Singer
Mr. Jeffrey S. Sites
Ms. Jennifer Sklar-Romano
Mr. David R. Sklaver
Dr. and Mrs. Jim Slater
Reverend William T. Slater
Mr. Ronald Slevin
Mr. Bill D. Smith
Mr. and Mrs. Brian Smith
Mr. Declan Smith
Mr. and Mrs. George Smith
Mrs. Holly Smith
Mrs. Ruth A. Smith
Mr. Chuck Smith-Dewey
Smithfield Foods, Inc.
Mr. Bruce Smylie
Mrs. Katherine Sobel
Mr. and Mrs. Joseph Sondej Jr.
Ms. Carol A. Sonnessa
Sonzogni, Bottitto & Fingerhut LLC
Soros Fund Charitable Foundation
Dr. and Mrs. Jack Soterakis
Mr. and Mrs. Ari Spar
Mr. Walter F. Spardel
Dr. Howard Spector
Ms. Anne Spitza
Mr. and Mrs. David Spring and Family
St. John Fisher College
St. Peter's Lutheran Church
Mrs. Carol Stanzione
Ms. Karen Staub
Mr. Jim Steber
Mr. Carl Steen
Mrs. Marcia Steinberg
Stellar Solutions Foundation
Mr. Robert Stellato and Ms. Debra
Scordino
Stephen and Shelly Verber Fund
Stephen J. Meoli Memorial Foundation
Mrs. Ruth B. Stern
Steven and Beverly Rubenstein
Charitable Foundation, Inc.
Mr. Frank Stiebel
Ms. Stephanie J. Stiefel
Mr. and Mrs. Stephen Stier
Mrs. Elizabeth Straight
Ms. Heidi E. Strom
Suffolk Games Enterprises, Inc.
Mr. Scott R. Sulzberger and Family
Mrs. Barbara Surdej
Mr. and Mrs. Len Susman
Mrs. Judy Taboada
Mr. and Mrs. Ross H. Taff
Talonvest Capital, Inc.
Ms. Taryn B. Tanzer
Ms. Linda S. Tardiff
Mrs. Mary M. Tassini
Mr. William J. Taylor and Ms. Vessie Ware
Mr. Larry Tchou
The Woodmere Club Charitable
Foundation
The Wool Family Foundation
Theatrical Protective Union
Mr. Francis Thompson II
Mr. Peter Thonis
Tiffany & Co.
Mrs. Tammy Tlachac
Mr. and Mrs. Robert B. Tober
Mrs. Gail Tomberg
Tommy Scogs Foundation, Inc.
TOPA Diagnostics
Towers Watson
Mr. Scott R. Treiber
Mr. William G. Trillo
Trinity United Methodist Women
Trippe Lite Manufacturing Co.
Mr. Richard B. Turan and Family
Turner Construction Company
TV One
TZP Cares Foundation
Alan and Robyn Udell
Mr. and Mrs. Arthur Udell
Mr. and Mrs. Mitchell Udell
United Way of Benton & Franklin
Counties
United Way of Bergen County
University Physicians, Inc.
Mrs. Elaine Unterman
Valero Texas Open
Mr. and Mrs. William Van Winkle
Mr. Billy W. M. Vanadia
Ms. Lisa M. Vandetti
Mr. George T. Varones
Mr. Anthony J. Vela
Mr. Vincent Vellucci
Alexis and Lou Ventre
Mr. George L. Venuto
Verizon Foundation
Mr. Stanley Vinton
Mrs. Chris Viola-Weiss
Mr. John Vissicchio
Mr. Domenick Vita
Vivid Entertainment LLC
Mrs. Kathleen C. Voigt
Mrs. Erica Vozzolo
Vubiquity
Mrs. Irene T. Wachter
Ms. Edith H. Wah
Mr. Joseph Wald
Mr. and Mrs. Christian Wall
Mr. and Mrs. Damian E. Wall
Mr. John Wallace
Mr. Todd Walsh
Mrs. Judi Walters
Mr. Wolfgang Wander
Mrs. Elizabeth Ward
Mr. Bruce Washburn and Ms. Joan
McCabe
Wasserman Family Foundation
Mrs. Becky S. Watson
Waveguide, Inc.
Mr. Daniel Wechter
Mrs. Alice Weed
Weinshel Goldfarb Foundation, Inc.
Mr. Colin Weir
Mr. Jeffrey Weiss
Ms. Joelle C. Weiss
Mr. and Mrs. Scott Weiss
Wellfleet Foundation, Inc.
Community Events (events raising at least $1,000)
Mrs. JoAnn Welter
Mr. Todd A. Wendling
Westlake Village Inn
Mr. Michael J. Whalen
Mr. Kevin P. Wheeler
White Plains Hospital Center
Dr. David Whitlock
Dr. Mark Wilkinson
Ms. Nanci Wilkinson
Mr. Robert Willens
Drs. Derek and Valerie Williams
Athletics
Ben Asen
Teach A Man To Fish Foundation
Telco Access Partners LLC
Mr. Frank P. Terzo
Mrs. Rachel Teslenko
Test Force Corporation
The Anbinder Family Foundation
The Anikstein Family Foundation, Inc.
The Bowling Family Foundation
The Buller Foundation
The Carl Marks Foundation, Inc.
The Custard Hut
The Darrel & Audrey Weber Foundation
The David and Lucile Packard
Foundation Matching Gift Program
The Dunphy Family Fund
The Grimaldi Foundation
The Hagani Foundation, Inc.
The Hanna Charitable Fund
The Heiser Family Fund
The Hollander Foundation
The Irwin & Daryl Simon Foundation
The Lawrence Schacht Memorial Fund
The Martin Agency
The McKeever Family Charitable Fund
The Oatley Team
The Plaut Family
The Phelan Foundation
The Prudential Foundation Matching
Gifts Program
The Ray Family Charitable Gift Fund
The Ruth & Louis Gerstle Foundation, Inc.
The Shaheen Family Fund
The Swell Dudes
The Vincent Dowling Family
Foundation Inc.
The Weather Channel
The Weinreb-Berenda-Carter
Foundation Inc.
The West Family Foundation
The William & Phyllis Mack Family
Foundation, Inc.
Mr. Gregg Willinger
Mr. Bradford Wilsted
Mr. Fred Wistow
Mr. Steven Witt
Wolf, Rifkin, Shapiro, Schulman &
Rabkin, LLP
Mr. Raymond Wood
Mrs. Janet Wortman
Mr. and Mrs. Peter A. Wright
Mrs. Connie Wuestenhagen
Lt. Col. Barbara Wunderlich
Ms. Carole Yaley Corso
Mrs. Patricia M. Yarbrough
Mrs. Adrienne Yarnold
Mr. Randy Zablo
Mr. Edward Zadigan
Mrs. Jennifer Ziegler and Family
Ms. Shari Zimmerman
Beginning in 2016, our annual
report will only list contributions
that total $2,500 or more.
This list of donors has been prepared
with the greatest of care. We sincerely
regret any errors or omissions. If you
have questions about this list, please
contact The Lustgarten Foundation at
516.803.2304.
Bedford High School Volley for the Cure
Canter for the Cure in Memory of
Arlene Bates Toyne
Charity Ride at Flywheel
Columbia Trail Tromp Memorial for
Bill Harrington Sr.
Fundraiser in Memory of Claire Rose Bavaria
Haymakers for Hope Inc. Fundraiser in
Honor of Jack Brill
Hoops for a Cure
Iowa Classic/Janesville Cedar River Riders
Jazzercise Group of Upper Arlington
Charity Event
Jenn’s Countryside Ride for Cancer/Motorcycle Ride
Kodiak Swim Fundraiser in Honor of Carl Smith
Legend Shotokan Karate Fundraiser
Maryland Men’s Lacrosse Purple Out
Massapequa High School Basketball “Alumni
Game” Charity Fundraiser
Miles 4 Michelle
Pure Barre Chicago River North – Pure Give Class
Purple Pucks for Pancreatic Cancer Research
Score for the Cure
Shooting for a Cure for Pancreatic Cancer
Steve Koziol Memorial Salmon Derby
Strike Out Pancreatic Cancer
Team Dream Swim
Tour De Pour
Village Cup Regatta
Wiffle Ball Tournament in Honor of
Steve Brosky Jr.
Endurance Events
2015 New York City Half Marathon: Sandra Duffy,
Linda Gennusa and William Nugent
Atlanta Track Club’s Thanksgiving Half Marathon
in Honor of Rick Sforzini
BJ Walks America
Ironman Lake Placid Ultra Triathlon - David Swezey
Love of Bill Tour
Malibu Triathlon - Lindsay Malison Newbegin
Race the Lake Half Marathon
RJA Memorial Mighty Montauk Triathlon
Golf Outings
AC DC Golf Tournament
AOH Division2 Golf Outing in Honor and
Memory of Msgr. Jim Kissane
ASIS Long Island Golf Outing
Bill Tamburro Jr. Golf Tournament
Brett Rollman Memorial Golf Outing
Bretton Woods Golf Club in Memory of
Tony Silkorski
Brian McGovern Memorial Golf Tournament
Carol B. Smith Memorial Golf Tournament
Carol Van Auken Golf Outing
Chubb Charity Challenge
Colin Wardle Memorial Golf Tournament
Croatian American Charitable Foundation Golf
Outing in Memory of Val Blaskovic
Debbie Open Golf Outing
Eddie Ivanoski Memorial Golf Tournament
Golf Outing in Honor of Jeff Pirozzi
Hit and Run Golf Outing
Hoopalator Open Golf Tournament
Howard Shapiro Golf Outing
Jack Haley Golf Tournament
Jeffrey K. Elder Memorial Golf Tournament
JFK Air Cargo Golf Outing
Jim Alberto Memorial Golf Classic
John V. Duffy Memorial Golf Outing
Laurie Milotte Golf Tournament
Loren Findorak Pancreatic Cancer Golf Outing
No One Fights Alone Memorial Golf Outing
Old Oaks Charity Weekend
Rensselaer Honda’s Tom Gorman Memorial
Golf Outing
Rock Hill Golf and Country Club 50th
Anniversary Party
Scramble for Shelly
Steve Hatje Golf Outing
Swing Fore Hope
Terry Hagen Memorial Golf Tournament
The Gene Toth Memorial Golf Tournament
The Knicker Open at Medinah Country Club
The Larry Golf Classic
The Lustgarten Foundation Golf Outing
Milestone Celebrations
In Memory of Keith Malison
In Memory of Sydney Lustgarten
In Memory of Vincent Peter Magro
In Memory of Walter T. Bohorquez
Jerry’s Pals - Amy’s Bat Mitzvah Project
Mindy and Marc’s Wedding
Peter “Steve” MacDonald Fundraiser
Sarah Curtis’ Bat Mitzvah Fundraiser
Wedding Donations in Memory of Laura Lyn Inglis
Andie Novenstein’s Bat Mitzvah Project in
Memory of Philip Scheier
Celebration of Life in Memory of Carl Silvestrone
George Wong Memorial Fund in Memory of
Mary Greta Ladiana
Social Events
A Cure for Commie
Americana Manhasset Champions for Charity
Barb Reuteman Bags Tournament for
Pancreatic Cancer
Ben Diamond Bake Sale
Big Daddy’s Poker Tournament
Bracelets for Dave Gurley
Bring a Buck in Honor of Ronald R. Holman
Cars vs. Cancer Car Show
Cellini Lodge #2206 Charitable Foundation
Pasta Night
Cheers to a Cure
Chop and Stout Month at Shoreline Brewery
Circle of Hope
Custer’s Cruise In
EyeKrafters Medical Optics Grand Opening
Frenz for a Cause Masquerade Extravaganza
Ga May - in Memory of Mark Kuller
Go With Courage
Immaculate Heart Academy Knitting Club
International Tabletop Day for Pancreatic
Cancer Research
Jason Paver Fundraiser
Jewelry Trunk Show in Memory of Louis Fortunoff
Leonard Park Wines and Spirits Event in Honor of
Joseph Larizza
Let’s Help Find a Cure in Memory of Lou DeSciloi
LinkedIn Fundraiser
Long Island Craft Beer Week
Luau for Pancreatic Cancer Research
Mid Atlantic Chili Heads
Mo-Hawk Less Cancer Motorcycle Benefit Ride
and Jam
Murder Mystery Fundraiser
Nancy Wernikoff’s Tea in Memory of Serge
Neuron Mirror Books
Night Out for A Cure
No Shave November
Pancakes for a Purpose in Memory of David A.
Anstadt and John Bradley
Pastime Athletic and Social Club Inc. Lobster Bake
Pat’s Place Fundraiser in Memory of
Ralph Bruschini
Punch Out Pancreatic Cancer
Purple Pumpkins for Pancreatic Cancer Awareness
and Search for A Cure in Memory of Joseph T.
Alessi and George Solomos
Race 4 A Cure
Raising Hope for Others in Memory of
Kathleen Loomis
Riverdale Country School
Road Knight Auto Club Annual Car Show
Sandra’s Comfort Raddle the Bottom Bluegrass &
Folk Festival
Southeast Foraging Dinner
St. Fisher College Pie in the Face Fundraiser
St. Peter’s Lutheran Church Annual Harvest Festival
Steve’s Happy Hour
Susiepalooza
The Ambrosio & Bellotti Charitable Foundation,
Inc. Fundraiser
The Rook Pub Bartending for Charity
Tribe Body Presents a SPOOK-TACULAR Event
Walks & Runs
5cacia Run for Pancreatic Cancer at Ohio University
5K Beer Run/Walk in Memory of Beth Moore and
Thomas Lesselyong
Andrea’s Adventure Presents: Hope Heart and Sole
Bob Kochka Memorial 5K Run/Walk
Chuck Jenkins Walk/Run
Crush Pancreatic Cancer 5K/Chillin’ for Chili
Cook-Off
Gloria Prodoehl and Diana Agozzino Memorial
Run/Walk
Hope Begins with Me
Howie Levy Cross Country Ski Family Fun Run
Julia’s Run for Pancreatic Cancer Research
Lake Geneva Walk for Sandy
Making Every Mile Count in Memory of Helene Miller
Pound the Pavement for Purple 5K Run/Walk
Purple Ribbon 5K Run/Walk
Rick’s Run
Rock and Run 5K
Sale Machine Walking Challenge
Schulze & Burch Biscuit Co./Tripp-Lite Race Walk
Championships
Sherry Shumaker Memorial Pancreatic Cancer
5K Run/Walk
Snohomish River Run
The Michael Abelon Walk
Workplace Programs
BTIG Charity Day in Honor of Harriet Plank
DreamLine Partners and Employees
1111 Stewart Avenue
Bethpage, New York 11714
Phone: 1-866-789-1000
www.lustgarten.org

2015 - Lustgarten Foundation

Transcription

Similar documents

"HEY, THAT TICKLES"—Eleven-month

File

Mrs. Starr`s Second Grade Class loves going to the computer lab

May 18, 2012 - Urbana City Schools

Funeral Services For Mrs. Jennie Thompson are rteld

BOSSLey Biz - Bossley Park High School

mrs. flutterbee`s music and movement assemblies

Dear New Friend, I am so excited to hear that you are in my class

Welcome to Year 9 2015

2010 Part 2